Document:

Exhibit 10.6 

 

CERTAIN CONFIDENTIAL
INFORMATION IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL
IF PUBLICLY DISCLOSED

 

AMENDED AND RESTATED
MANAGEMENT SERVICES AGREEMENT

 

THIS AMENDED AND RESTATED MANAGEMENT SERVICES AGREEMENT
(this “Agreement”), dated January 12, 2021 and effective as of September 19, 2018, is by and between TOI
Management, LLC, a Delaware limited liability company (“Management”) and The Oncology Institute CA, a Professional
Corporation (formerly known as Richy Agajanian, M.D., a Professional Corporation), a California professional corporation (the “Practice”),
for itself and on behalf of its subsidiaries (whether currently operating or hereafter created or acquired) (collectively, the “Subsidiaries”).

 

R E C I T A L S

 

A.            Management
provides physician practice management services and has expertise in billing compliance programs and in related practice and other ancillary
management and administrative activities for and on behalf of clients.

 

B.            Practice
is a California professional corporation, whose physician employees are all duly licensed and authorized to practice medicine in the
State of California and other states, as applicable (each a “State” and collectively, the “States”),
and who provide professional medical services at the medical offices described on Exhibit A attached hereto, as may be modified
from time to time (each a “Medical Office” and collectively, the “Medical Offices”);

 

C.            Practice’s
Subsidiaries are engaged in the provision of certain ancillary services, including the conduct of research clinical trials, and any other
activities permitted by applicable laws as further described on Exhibit B, which may be updated from time to time (in the
event that any of the Subsidiaries are engaged in the practice of medicine in the States, such Subsidiary shall be included in the definition
of “Practice” for the purposes of this Agreement);

 

D.            Practice
desires to engage Management to provide certain medical office space as delineated on Exhibit A, and as may be modified by
the parties from time to time and, Practice desires to retain Management to provide certain management, supervisory and administrative
services required to operate the non-medical aspects of Practice’s and Subsidiaries’ operations, as well as to improve the
efficiency of Practice’s practice operations on the terms and conditions set forth in this Agreement (collectively, the “Management
Services”).

 

E.            Practice
and Management desire to enter into this written agreement to provide a full statement of each party’s respective rights and responsibilities
during the term of this Agreement.

 

NOW,
THEREFORE, in consideration of the above recitals, the terms and conditions hereinafter set forth, and other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:

 

		1.	NATURE OF RELATIONSHIP

 

Except as prohibited by applicable laws regarding the practice
of medicine and subject to the limitations set forth in this Agreement, Practice hereby engages Management to provide and/or arrange
for the provision of the Management Services as described in Section 5 below to and on behalf of Practice and the Subsidiaries,
and Management does hereby accept such engagement to provide the Management Services to and on behalf of Practice and Subsidiaries in
accordance with the terms and conditions contained in this Agreement. Management will be the Practice’s and Subsidiaries’
exclusive provider of such Management Services.

 

    1

     

    

 

		2.	TERM OF AGREEMENT

 

The initial term
of this Agreement shall commence as of the date first set forth above, and shall continue thereafter for a period of twenty (20) years,
unless earlier terminated in accordance with Section 11 below. Thereafter, this Agreement shall be automatically renewed
upon the same terms and conditions for successive one (1) year terms, unless either party provides to the other party at least ninety
(90) days’ prior written notice of such party’s desire to let this Agreement expire as of the end of the then current term
of this Agreement.

 

		3.	DUTIES AND RESPONSIBILITIES OF PRACTICE AND SUBSIDIARIES

 

3.1            Qualifications
and Credentials. At all times hereunder, each physician employee of Practice and Subsidiaries (as applicable) shall (a) be duly
licensed and authorized to practice medicine in the applicable State, (b) maintain a valid, unrestricted DEA registration, (c) perform
the practice of medicine at the Medical Offices in accordance with all applicable laws, and with prevailing standards of care and as
required by all applicable managed care contracts, (d) maintain his or her skills through continuing education and training, (e) maintain
eligibility for insurance under the professional liability policy or policies carried by Practice, and (f) satisfy such other requirements
as are reasonably requested by Practice, in consultation with Management.

 

3.2            Standards
of Practice. Practice shall at all times comply with all applicable laws and governmental regulations concerning the licensure and
practice of medicine in the States (including legally-binding guidance made available by the applicable State’s medical board regarding
the corporate practice of medicine). Subsidiaries shall comply with applicable laws concerning such Subsidiary’s activities and
business.

 

3.3            Hours
of Operation. The hours of operation of the Medical Offices shall be Monday through Friday (or as otherwise determined by the parties),
excluding holidays, during such hours as may be mutually agreed to by Practice and Management, as well as such additional weekend and
holiday hours as may be mutually agreed to by Practice and Management. The Subsidiaries shall operate at such times as are mutually agreed
to by the parties.

 

3.4            Clinical
Professionals. Practice and Subsidiaries (as applicable) will employ or engage all clinical professionals, including all nurse practitioners,
nurses and other allied health professionals (the “Clinical Professionals”), necessary to conduct, manage and operate
in a proper and efficient manner the Practice at the Medical Offices. Such professionals will be engaged or employed pursuant to written
agreements developed by Management in consultation with Practice, subject to final approval by Practice (which shall not be unreasonably
withheld, conditioned, or delayed).

 

    2

     

    

 

3.5            Duty
to Cooperate. The parties acknowledge that mutual cooperation is critical to the performance of their respective duties and obligations
under this Agreement. To ensure the communication necessary for mutual cooperation, the Practice will permit a representative designated
by Management (the “Management Representative”) to attend and participate (in a non- voting capacity) in all meetings
of the Practice’s and the Subsidiaries’ equityholders called pursuant to the its governing documents or as otherwise required
by applicable law. Practice will give Management at least five calendar days’ prior written notice of each such meeting, specifying
the date, time and place of the meeting and, if the meeting is a special meeting, the purposes for which the meeting is called.

 

3.6            Managed
Care Agreements. Practice shall participate in all managed care agreements identified by Management and presented to Practice for
execution.

 

		4.	INDEPENDENT CONTRACTORS.

 

Management on
one hand and Practice and Subsidiaries on the other hand are now and will remain as to each other separate and independent. In the performance
of this Agreement, it is mutually understood and agreed that each party is at all times acting and performing under this Agreement as
an independent contractor, and not as an employee, joint venturer or partner of the other party. Neither party shall have any right,
authority or duty to act for the other party, except as otherwise agreed to in this Agreement.

 

		5.	MANAGEMENT’S OBLIGATIONS.

 

For each month
during the term of this Agreement, Management through its employees and agents shall provide the following Management Services in a competent,
efficient and reasonably satisfactory manner:

 

5.1            Medical
Office. Management shall provide the Medical Offices delineated on Exhibit A for Practice’s use for so long as
this Agreement is in effect. Practice shall use and occupy the Medical Offices solely as medical office space during normal business
hours, in accordance with the time schedules developed by Practice and Management pursuant to Section 3.3
above. The Medical Offices provided by Management may be changed, replaced and/or added to without the prior written consent
of Practice, but only if Management in good faith determines such a change to be reasonable under the circumstances. Any such substitute
or replacement space, if any, shall thereafter be deemed to be a Medical Office for purposes of this Agreement. Management shall consult
with Practice from time to time as appropriate regarding the condition, use and needs of the Medical Offices. Management shall provide
to the Subsidiaries such reasonable office space as may be deemed necessary from time to time for such Subsidiary’s operation in
accordance with applicable laws.

 

5.2            Equipment,
Fixtures, Furniture and Improvements.

 

(a)            Management
shall furnish for use by Practice and Subsidiaries, as applicable, certain medical equipment, office equipment, fixtures, furniture and
leasehold improvements (collectively, the “Equipment”) deemed by Management to be reasonably necessary for the proper
and efficient operation of the Medical Offices, the Practice and the Subsidiaries. Management and Practice may mutually agree
to the selection of any replacement or additional equipment. Any such replacement or additional equipment, if any, shall thereafter be
deemed to be the Equipment for purposes of this Agreement.

 

    3

     

    

 

(b)            Management
shall maintain the Equipment in good repair, condition and working order, ordinary wear and tear excepted, and shall furnish all parts,
mechanisms, devices and servicing required therefor, including, without limitation, all preventive and routine maintenance as may be
necessary and appropriate to maintain the Equipment in a proper state of repair and serviceability.

 

(c)            The
Equipment provided by Management under this Agreement shall at all times be and remain the sole property of Management. Neither Practice
nor any Subsidiary shall cause or permit the Equipment to become subject to any lien, levy, attachment, encumbrance or charge, or to
any judicial process of any kind whatsoever, and shall not remove any Equipment from the Medical Offices or other office locations, except
to the extent permitted by written rules and procedures adopted from time to time by Management.

 

5.3            Management
and Supervision. Practice hereby appoints Management as its sole and exclusive manager and administrator of all non-clinical functions
and services at the Medical Offices and all non-professional and non-clinical functions of the Subsidiaries, and Management agrees to
accept full responsibility for such management and administration to the extent that such services are required for and directly related
to the such business functions located at the Medical Offices and other locations of the Subsidiaries, including:

 

(a)            Records
Maintenance. The maintenance, custody and supervision of business records, papers, documents, ledgers, journals and reports relating
to the business operations of the Practice and the Subsidiaries. All such records, papers, documents, ledgers, journals and reports shall
be and remain the property of the Practice.

 

(b)            Accounting.
The administration of accounting procedures, controls, forms and systems.

 

(c)            Financial
Reporting. The preparation of monthly, quarterly and annual financial reports, as appropriate, reflecting the business operations
conducted at the Medical Offices and by the Subsidiaries.

 

(d)            Financial
Planning. The financial planning for the business operations conducted by the Practice and the Subsidiaries, including the preparation
of annual capital and operating budgets in consultation with the Practice.

 

(e)            Accounts
Payable Processing. The processing and payment of accounts payable.

 

(f)            Accounts
Receivable Processing.     The processing and collection of accounts receivable
including the preparation, distribution and recordation of all bills and statements for professional medical and ancillary or other services
rendered on behalf of Practice and the Subsidiaries as described in greater detail in Section 5.7 below, and including the
billing, processing and completion of any reports and forms that may be required by third party payors or customers.

 

    4

     

    

 

(g)            Employee
Records and Payroll Processing. The provision and processing of all employee record keeping, payroll accounting, including social
security and other payroll tax reporting and insurance for all employees of Practice and the Subsidiaries, and for all other persons
rendering services on behalf of Practice or on behalf of the Subsidiaries.

 

(h)            Employee
Benefits Administration. The administration of payroll taxes, workers’ compensation insurance, unemployment insurance, qualified
retirement plans, group insurance benefits, and any other benefit programs adopted by Practice and the Subsidiaries for its employees.
Notwithstanding the foregoing, each party shall be solely responsible for and shall comply with all applicable laws pertaining to employment
taxes, income withholding, unemployment compensation contributions and other employment-related matters applicable to that party, it
being understood that Management shall provide service to Practice and Subsidiaries (where applicable) to assist such entity in satisfying
its obligations described above, but such services shall not impose upon Management any liability that is retained by Practice or any
Subsidiary hereunder.

 

(i)            Maintenance
and Security Service. Management shall provide or arrange for the proper maintenance and cleanliness of (including refuse disposal),
and shall provide adequate security services for, the Medical Offices and at Subsidiaries’ locations.

 

5.4            Supplies.
Management shall furnish such supplies as may be deemed reasonably necessary by Management for the proper and efficient operation of
the Practice and the Subsidiaries, including, but not limited to, stationery, statement forms or invoices, office supplies, copier paper
and medical supplies (including pharmaceuticals in accordance with applicable federal and state law). Notwithstanding the foregoing,
Management shall consult with Practice from time to time as appropriate in connection with the purchase of such supplies.

 

5.5            Utilities.
Management shall make all arrangements for, and pay all costs incidental to, all utilities necessary for the effective operation of the
Practice and the Subsidiaries, including, without limitation, gas, electricity, water, telephone, trash collection and janitorial services.

 

5.6            Patient
Records. Management shall provide all services related to the maintenance of patient medical records, including record retrieval
services. Except as set forth in Section 8 below, all patient medical records shall be Practice’s or the Subsidiaries’
property, as applicable, and Management shall maintain the confidentiality of all such patient medical records in accordance with applicable
laws.

 

5.7            Billing
and Collection.

 

(a)            Billing
Agent. To relieve Practice and the Subsidiaries of the administrative burden of handling the billing and collection of fees for professional
medical and ancillary or other services rendered by or on behalf of Practice or any Subsidiary during the term of this Agreement, Management
shall be responsible, on behalf of Practice (or Subsidiary) and on the billhead or invoices of Practice (or Subsidiary) as its agent,
for billing and collecting the charges made with respect to all professional medical and ancillary or other services rendered
by or on behalf of Practice or Subsidiary during the term of this Agreement. The Practice, and each Subsidiary, in accordance with applicable
law, hereby grants to Management an exclusive, special power of attorney and appoints Management as an exclusive and lawful agent and
attorney-in-fact, and Management hereby accepts such special power of attorney and appointment, for the purposes of fulfilling its obligations
set forth in this Section. Notwithstanding anything herein to the contrary, Management shall have no authority or control over decisions
regarding coding and billing procedures for patient care services.

 

    5

     

    

 

(b)            Documentation
and Collection. Practice and the Subsidiaries agree to keep and provide to Management all documents, opinions, diagnoses, recommendations,
and other evidence and records necessary for the purpose of supporting fees charged for professional medical and ancillary or other services
from time to time. Management shall maintain complete and accurate records, consistent with the general practices of Management from
time to time, of all fees, charges and billings of all services contemplated hereby. It is expressly understood that the extent to which
Management will endeavor to collect such fees, the methods of collecting, the settling of disputes with respect to charges and the writing
off of fees that may be or appear to be uncollectible shall at all times be at the reasonable discretion of Management, and Management
does not guarantee the extent to which any fees billed will be collected. Practice or Practice’s duly authorized agent shall have
the right at all reasonable times and upon the giving of reasonable notice to examine, inspect and copy the records of Management pertaining
to such fees, charges, billings, costs and expenses.

 

(c)            Fee
Schedule. Prior to or concurrent with the execution of this Agreement, Practice shall deliver to Management an initial schedule of
fees for all of Practice’s and the Subsidiaries’ charges (the “Fee Schedule”), which Fee Schedule shall
not exceed the reasonable, usual and customary charges for professional medical and ancillary services provided in the community surrounding
the Medical Offices. Thereafter, Practice shall consult with Management at least thirty (30) days prior to any changes in or additions
to such Fee Schedule, and all such changes or additions to the Fee Schedule shall be in writing to Management.

 

(d)            Bank
Accounts. Practice authorizes Management to establish, for the Practice’s benefit, certain bank accounts including one or more
designated the “Non-Government Lockbox Account(s)”, one or more designated the “Government Lockbox Account(s)”
and one or more designated the “Operating Account(s)”. Each Government Lockbox Account will be in Practice’s
name, and the Practice will have sole ownership and control over each Government Lockbox Account. Each Operating Account and Non-Government
Lockbox Account will be in Management’s name and maintained for the Practice’s benefit. Promptly upon request, thePractice
and, as applicable, any Subsidiary, shall execute and deliver to Management suchdocuments and instruments as may be necessary to evidence
power of attorney granted by Practice (and, if applicable, Subsidiary) to Management.

 

    6

     

    

 

(e)            Non-Government
Lockbox Accounts and Government Lockbox Accounts. Other than payments from Federal Health Care Programs (as defined in 42 U.S.C.
 § 1320a-7b(f), or any similar or successor programs) all payments due in respect of services rendered and products provided by or
on behalf of the Practice, and any other amounts payable to the Practice or to the Subsidiaries, will be directed to the Non-Government
Lockbox Accounts. All payments from Federal Health Care Programs will be directed to the Government Lockbox Accounts. The Practice and,
as applicable, the Subsidiaries, will enter into an agreement with a financialinstitution chosen by the parties to (i) establish
and service the Non-Government LockboxAccounts and Government Lockbox Accounts subject to the requirements of this Agreement (including
the power of attorney granted above), (ii) facilitate the collection and negotiation of payments from Federal Health Care Programs
and the deposit of such payments into the Government Lockbox Accounts and (iii) sweep all funds from the Non-Government Lockbox
Accounts and Government Lockbox Accounts into the Operating Accounts on a daily basis. Any such authorization or instructions relating
to Government Lockbox Accounts may be revoked by Practice at any time; provided, however, that any modification or revocation of such
authorization and instructions with respect to either the Government Lockbox Accounts or the Non-Government Lockbox Accounts by Practice
without Management’s prior written consent will be in material breach of this Agreement and cause for immediate termination of
this Agreement under Section 11. The Practice, Management
and the financial institution maintaining the Non-Government Lockbox Accounts will also enter into a deposit account control agreement
pursuant to which such financial institution agrees to follow Management’s instructions with respect to the Non- Government Lockbox
Accounts without requiring Practice’s or Subsidiary’s further consent.

 

(f)            Operating
Accounts. Management will use the Operating Accounts to receive funds from the Non-Government Lockbox Accounts and the Government
Lockbox Accounts and pay Practice and Subsidiary expenses, amounts due under this Agreement (including the Management Fee) and the Deficit
Funding Loan Agreement and such other expenses as Management may pay on the Practice’s and Subsidiaries’ behalf. Such persons
as Management may designate from time to time will be authorized signatories on the Operating Accounts (“Authorized Signatories”).
Any modification or revocation of such authorization and instructions by Practice without Management’s prior written consent will
be in material breach of this Agreement and will be cause for immediate termination under Section 11.

 

(g)            Monthly
Report. On or before the fifteenth (15th) day of each calendar month during the term of this Agreement, commencing with the second
such month, and continuing on or before the fifteenth (15th) day of each calendar month thereafter until six (6) months following
the expiration or earlier termination of this Agreement, Management shall furnish Practice with a statement of all collected revenues
for the previous calendar month.

 

(h)            Survival
of Collection Obligation. For a period of six (6) months following the expiration or earlier termination of this Agreement,
Management shall continue to be obligated to bill the charges made with respect to all professional medical and ancillary or other services
rendered by or on behalf of Practice during the term of this Agreement and to collect such charges as well as the collected revenues
billed by Management prior to the expiration or earlier termination of this Agreement; provided, however, that Management shall have
no obligation to bill or collect the charges for any professional medical and ancillary or other services rendered by or on behalf of
Practice after the expiration or earlier termination of this Agreement. Following the expiration or earlier termination of this Agreement,
Management shall continue bill and collectthe collected revenues in accordance with the terms and conditions set forth in this Section 5.7.

 

    7

     

    

 

5.8            Staffing
of Medical Offices. Management shall, on behalf of Practice and the Subsidiaries, provide such non-physician personnel as may be
reasonably necessary to enable Practice and the Subsidiaries to carry out and perform their professional medical services, subject
to the following:

 

(a)            Management
shall, on behalf of Practice and the Subsidiaries, provide all non-physician support personnel including without limitation all receptionists,
medical assistants, technicians, secretaries, clerks, management and purchasing personnel, janitorial and maintenance personnel, and
such other personnel as may be reasonably necessary for the proper and efficient operation of the Practice and the Subsidiaries (collectively,
the “Support Personnel”).

 

(b)            Management
shall, on behalf of Practice and the Subsidiaries: (i) train, manage and supervise all Support Personnel; (ii) hire and fire
all Support Personnel; (iii) determine the salaries, fringe benefits, bonuses, health and disability insurance, workers’ compensation
insurance and any other benefits for all Support Personnel; and (iv) be responsible for any appropriate disciplinary action required
to be taken against Support Personnel. Notwithstanding the foregoing, Management shall consult with the Practice from time to time as
appropriate in connection with the hiring, performance appraisal and termination of the Support Personnel and Practice’s determination
with respect to selection, hiring and firing of all allied health staff and medical assistance relating to such staff’s clinical
competency or proficiency shall control. Notwithstanding anything herein to the contrary, with regard to those Support Personnel who
are professionals required by law to be supervised by physicians or the Practice, Practice shall be solely responsible for the training
and supervision of such Support Personnel as it relates to clinicalmatters, including clinical competency and proficiency.

 

(c)            In
recognition of the fact that the Support Personnel provided by Management to Practice under this Agreement may perform similar services
from time to time for others, this Agreement shall not prevent Management from performing such similar services or restrict Management
from using the Support Personnel provided to Practice under this Agreement to perform services for others. Management will make reasonable
efforts, consistent with sound business practice, to honor the specific requests of Practice with regard to the assignment of Support
Personnel by Management.

 

5.9            Additional
Services to Subsidiaries. Management shall, on behalf of the Subsidiaries, provide such other services as may be identified on Exhibit C
from time to time.

 

5.10            Third
Party Payor Contracting. Management shall, on behalf of Practice, negotiate the terms and conditions of the Practice’s third
party payor agreements; provided, however, that Management will not be responsible for setting the parameters under which the
Practice will enter into contractual relationships with third-party payors.

 

5.11            Management’s
Right to Subcontract. Management shall be entitled to subcontract with any other persons or entities for all or any portion of the
services Management is required to provide or furnish to Practice pursuant to this Agreement. Management may disclose any term of this
Agreement to any subcontractor of Management who performs services for Management on behalf of Practice.

 

    8

     

    

 

		6.	MANAGEMENT FEE.

 

6.1            Compensation
of Management. Practice shall pay to Management, as full and complete compensation for the provision of the Management Services described
in this Agreement, the fee set forth on Exhibit D (the “Management Fee”). The Practice’s failure
to pay the Management Fee or reimbursable expenses when due will be considered a material breach of this Agreement.

 

(a)            The
parties have determined the Management Fee to be equal to the fair market value of the Management Services, without consideration of
the proximity of the Practice to any referral sources or the volume or value of any referrals from Management or any of its affiliates
to the Practice or from the Practice to Management or any of its affiliates, that is reimbursed under any government or private health
care payment or insurance program.

 

(b)            Payment
of the Management Fee is not conditioned upon a requirement that Practice make referrals to, be in a position to make or influence referrals
to, or otherwise generate business for Management or any of its affiliates or a requirement that Management or any of its affiliates
make referrals to, be in a position to make or influence referrals to, or otherwise generate business for the Practice. The Management
Fee does not include any discount, rebate, kickback or other reduction in charge.

 

(c)            Remittances
to the Practice of monies collected will be made net of that portion of the Management Fee then due and owing to Management pursuant
to this Agreement.

 

6.2            Expense
Reimbursement. In addition to the Management Fee, the Practice will reimburse Management for all operating expenses (including reasonable
travel, meals and lodging expenses) incurred by Management in connection with the provision of the Management Services; provided that
such expenses are included in the agreed upon budget for the Practice and Subsidiaries and are otherwise commercially reasonable.
Remittances to the Practice of monies collected will be made net of amounts for which Management is then due to reimbursement from the
Practice pursuant to this Agreement.

 

6.3            Deficit
Funding Loan Agreement. If Practice or Subsidiaries do not have sufficient cash to pay for their liabilities or financial obligations
(including any portion of the Management Fee or reimbursable expenses owed to Management hereunder), then Management may, in its sole
discretion, loan to Practice upon request funds for the purpose of enabling the Practice to pay its liabilities and meet its financial
obligations (“Advances”). Funded Advances will be added to the amounts owed by the Practice to Management pursuant
to that certain Deficit Funding Loan Agreement of even date herewith (“Deficit Funding Loan Agreement”) and will bear
interest as set forth in the Deficit Funding Loan Agreement. The Practice will repay funded Advances in accordance with the terms of
the Deficit Funding Loan Agreement.

 

6.4            Application
of Payments. Practice hereby directs Management, and Management agrees, to make payments from the Operating Account monthly for the
following purposes, in the order or priority set forth below:

 

(a)            First,
to pay all taxes of the Practice when due;

 

(b)            Second,
to pay compensation due to Practice’s employees (in accordance with the Practice’s budget mutually agreed upon by the parties)
and to the Support Personnel;

 

    9

     

    

 

(c)            Third,
to pay any refunds or other amounts owed to patients or third parties;

 

(d)            Fourth,
Management will be paid its reimbursable expenses in accordance with the terms set forth herein and any other cumulative direct costs
and expenses of operating Practice’s business;

 

(e)            Fifth,
Management will be paid its Management Fee in accordance with the terms set forth herein; and

 

(f)            Finally,
Management will be paid for any Advances in accordance with the terms set forth herein and in the Deficit Funding Loan Agreement.

 

		7.	CONDUCT OF MEDICAL
                                            PRACTICE; NO REFERRALS.

 

7.1            Practice
and, as applicable, the Subsidiaries shall be solely and exclusively in control of all aspects of the practice of medicine and the provision
of professional medical services to its patients, including all medical training and medical supervision of licensed personnel, and Management
shall neither have nor exercise any control or discretion over the methods by which Practice and the applicable Subsidiaries shall practice
medicine. Management’s sole function is to provide the Management Services to Practice and the applicable Subsidiaries in a competent,
efficient and reasonably satisfactory manner. The rendition of all professional medical services, including but not limited to, diagnosis,
treatment and the prescription of medicine and drugs, and the supervision and preparation of medical records and reports shall be the
sole responsibility of Practice and the applicable Subsidiaries. Notwithstanding anything herein to the contrary, Management will not:
(a) assign or designate specific clinical providers to treat specific patients; (b) assume responsibility for the care and
treatment of patients: (c) engage in any activity that constitutes the practice of medicine in any State or that would require Management
or its owners to have professional licensure under applicable laws; or (d) provide the Practice or any Subsidiary with any inducement
or remuneration in exchange for recommending to patients any services provided by Management.

 

7.2            Management
is not and shall not be responsible for the referral of patients to Practice, the Subsidiaries or physicians or for otherwise developing
a greater number of patient referrals to Practice, the Subsidiaries or physicians. The parties hereby acknowledge and agree that no benefits
to the parties hereunder require or are in any way contingent upon the admission, recommendation, referral or any other arrangement for
the provision of any item or service offered by Practice, the Subsidiaries or any of the physicians. Management shall neither have nor
exercise any control or direction over the number, type, or recipient of patient referrals to Practice or the Subsidiaries, and nothing
in this Agreement shall be construed as directing or influencing such referrals. Management has not guaranteed to Practice or the Subsidiaries
that the arrangements contemplated hereunder will guarantee any amount of income to Practice or the Subsidiaries. None of Management’s
activities contemplated under this Agreement or otherwise shall constitute obligations of Management to generate patient flow or business
to Practice. Further, there is absolutely no intent for Management in any manner to be compensated to generate patients for Practice
or the Subsidiaries. Rather, Practice and the Subsidiaries have engaged Management to manage the business aspects of Practice and the
Subsidiaries in order to enable Practice and the Subsidiaries to focus on delivering patient care.

 

    10

     

    

 

		8.	PATIENT RECORDS.

 

All patient records
and charts created in connection with the professional medical services provided by Practice and the Subsidiaries are Practice’s
and Subsidiaries’, as applicable, sole property. Notwithstanding the foregoing, Management shall have a continuing right to inspect
and copy (at Management’s expense) all records pertaining to Practice’s and the Subsidiaries’ patients, subject to
all applicable federal and state laws. The parties and their employees and agents shall maintain and safeguard the confidentiality of
all records, charts and other information generated in connection with the professional services provided hereunder in accordance with
all applicable federal and State laws, including, but not limited to, the Health Insurance Portability and Accountability Act of 1996
and the regulations promulgated thereunder by the United States Department of Health and Human Services (“HIPAA”).
To this end, the parties agree to abide by the HIPAA Business Associate Addendum attached hereto as Exhibit E.

 

		9.	INSURANCE.

 

9.1            Management
will purchase and maintain, on behalf of the Practice, or will assist the Practice in purchasing and maintaining all insurance policies
that are reasonable and customary for enterprises engaged in the activities a medical practice providing similar services to the Practice
is engaged in (including without limitation professional liability insurance for the Practice and the Clinical Professionals, comprehensive
general liability insurance, extended coverage insurance and workers’ compensation insurance), naming the Practice and the Clinical
Professionals as named insureds and Management as an additional insured under all such policies. Management shall, on behalf of each
applicable Subsidiary, obtain and procure such liability insurance as reasonably necessary for such Subsidiary’s activities, all
costs of which shall be paid by the applicable Subsidiary.

 

9.2            Management
shall obtain and maintain, at its sole expense, insurance policies that are reasonable and customary for enterprises engaged in the provision
of management services (including without limitation general liability, workers compensation, cyber liability, directors and officers
insurance).

 

		10.	INDEMNIFICATION.

 

Each party shall
indemnify, defend and hold harmless the other party from any and all liability, loss, claim, lawsuit, injury, cost, damage or expense
whatsoever (including reasonable attorneys’ fees and court costs) arising out of, incident to or in any manner occasioned by the
performance or nonperformance of any duty or responsibility under this Agreement and the HIPAA Business Associate Addendum attached hereto
by such indemnifying party, but only to the extent, and only in such amount, that such liability, loss, claim, lawsuit, injury, cost,
damage or expense is not covered and paid by third party insurance. The foregoing indemnification provision shall in all instances be
deemed to be subordinate to any third party insurance coverage that may cover all or any portion of any indemnified claim. This section
shall survive the termination or expiration of this Agreement.

 

    11

     

    

 

		11.	TERMINATION.

 

11.1            Events
of Termination. In addition to the expiration of this Agreement in accordance with Section 2 above, this Agreement may
be terminated upon the occurrence of any of the following events:

 

(a)            Mutual
Written Agreement. Mutual written agreement of the parties.

 

(b)            Material
Breach. In the event of a material breach of this Agreement by either party, the other party shall provide written notice upon the
defaulting party (the “Default Notice”) specifying the nature of the breach. In the event such breach is not cured
to the reasonable satisfaction of the non-defaulting party within thirty (30) days after service of the Default Notice, this Agreement
shall automatically terminate at the election of the non-defaulting party upon the giving of a written notice of termination to the defaulting
party not later than sixty (60) days after service of the Default Notice.

 

(c)            Insolvency.
If either party shall apply for or consent to the appointment of a receiver, trustee or liquidator of itself or of all or a substantial
part of its assets, file a voluntary petition in bankruptcy, or admit in writing its inability to pay its debts as they become due, make
a general assignment for the benefit of creditors, file a petition or an answer seeking reorganization or arrangement with creditors
or take advantage of any insolvency law, or if an order, judgment or decree shall be entered by a court of competent jurisdiction or
an application of a creditor, adjudicating such party to be bankrupt or insolvent, or approving a petition seeking reorganization of
such party or appointing a receiver, trustee or liquidator of such party or of all or a substantial part of its assets, and such order,
judgment or decree shall continue unstayed and in effect for a period of thirty (30) consecutive days, then the other party may terminate
this Agreement upon ten (10) days prior written notice to such party.

 

(d)            Immediate
Termination. Notwithstanding any other provision hereof, this Agreement may be terminated by Management for cause, upon one (1) days’
prior written notice to Practice, upon the occurrence of any of the following events:

 

(i)            In
the event of the termination or suspension of the license to practice medicine in the applicable State of any physician employee of Practice
who is not immediately removed by Practice from providing patient care services at a Medical Offices;

 

(ii)            In
the event of the conviction of any physician employee of Practice of any crime punishable as a felony under State law or of any other
crime involving moral turpitude or immoral conduct, and such physician employee is not immediately removed by Practice from providing
patient care services at the Medical Offices;

 

(iii)            In
the event that any act or omission on the part of Practice (or its physician employees) results in the cancellation of Practice’s
malpractice insurance, and Practice does not obtain (or Management is unable to obtain on behalf of Practice) new or substitute malpractice
insurance consistent with Section 9 above effective as of the cancellation date of such prior malpractice insurance;

 

    12

     

    

 

(iv)            In
the event of any withdrawal by Practice or a Subsidiary from the Operating Accounts, the Non-Government Lockbox Accounts or the Government
Lockbox Accounts, or any change by Practice in the written instructions relating to such accounts, in contravention of Section 5.7
of this Agreement;

 

(v)             In
the event of termination of the Deficit Funding Loan Agreement; or

 

(vi)            In
the event of the attempted assignment or other unauthorized delegation of any of Practice’s rights or obligations under this Agreement.

 

(e)            Termination
For Health Care Regulations. In the event that legal counsel for either party determines that more likely than not this Agreement
is in violation of any federal statute, rule or regulation, or any State statute, rule or regulation, including, but not limited
to, any medical and state health care programs, fraud and abuse or state laws governing referral fees and fee-splitting, then the parties
agree to negotiate, in good faith, amendments to this Agreement to conform to such statute, rule or regulation. If the parties are
unable to negotiate such amendment in good faith within sixty (60) days, then, in such event, this Agreement may be immediately terminated
by either party upon written notice to the other party.

 

11.2            Effect
of Termination. Promptly (but in any event within ten (10) calendar days) after the termination or expiration of this Agreement,
the Practice will pay to Management all Management Fees earned or accrued under this Agreement through the termination date, and reimburse
all reimbursable expenses incurred before the termination date. Repayment of any Advances will made as set forth in the Deficit Funding
Loan Agreement. Termination of this Agreement shall not release or discharge either party from any obligation, debt or liability which
shall have previously accrued and remain to be performed upon the date of termination. All obligations and rights expressly extended
beyond the Term, including but not limited to Sections 5.7(h), 8, 10, 11.2, 13-28, will survive the
expiration or termination of this Agreement.

 

		12.	ASSIGNMENT.

 

Nothing contained
in this Agreement shall be construed to permit assignment by Practice of any rights or duties under this Agreement, and such assignment
is expressly prohibited without prior written consent of Management. Any attempted assignment by either party shall be null and void
and of no force or effect. Management may freely assign this Agreement or any rights under this Agreement, or delegate any duties under
this Agreement without the Practice’s consent: (i) to a parent, subsidiary, or affiliate of Management, (ii) as a collateral
assignment to one or more lenders or agents for any lenders, or (iii) to any Person: (A) into which Management merges or consolidates,
(B) acquiring all or substantially all of Management’s assets, or (C) acquiring control of Management by equity or membership
interest purchase.

 

		13.	CONFIDENTIALITY

 

Neither party
shall disclose this Agreement or the terms thereof to a third party, except as otherwise required by law, without the prior written consent
of the other party, other than to such party’s legal and financial advisors.

 

    13

     

    

 

		14.	RESTRICTIVE COVENANTS.

 

14.1            Proprietary
Information. Practice recognizes that due to the nature of this Agreement, Practice (and its physician employees) will have access
to information of a proprietary nature owned by Management, including, but not limited to, any and all documents bearing a Management
form number or other identifying mark of Management, any and all computer programs (whether or not completed or in use), any and all
operating manuals or similar materials that constitute the non-medical systems, policies and procedures, methods of doing business developed
by Management, administrative, financial affairs and other information utilized by Management. Consequently, Practice acknowledges and
agrees that Management has a proprietary interest in all such information and that all such information constitutes confidential and
proprietary information and the trade secret property of Management. Practice hereby expressly and knowingly waives any and all rights,
title and interest in and to such trade secrets and confidential information and agree to return all copies of such trade secrets and
confidential information related thereto to Management at Practice’s expense, upon the expiration or earlier termination of this
Agreement.

 

14.2            Nondisclosure.
Each party further acknowledges and agrees that each party is entitled to prevent each party’s competitors from obtaining and utilizing
its trade secrets and confidential information. Therefore, each party agrees to hold the other party’s trade secrets and confidential
information in the strictest confidence and to not disclose them or allow them to be disclosed, directly or indirectly, to any person
or entity other than those persons or entities who are employed by or affiliated with either party, without the prior written consent
of the other party. During the term of this Agreement, neither party shall disclose to anyone, other than persons or entities who are
employed by or affiliated with either party, any confidential or proprietary information or trade secret information obtained by a party
from the other party, except as otherwise required by law. After the expiration or earlier termination of this Agreement, neither party
(and each of their contractors and employees) shall not disclose to anyone any confidential or proprietary information or trade secret
information obtained from the other party, except as otherwise required by law or upon the prior written consent of the other party.

 

14.3            Noncompete.
During the Restricted Period (as defined below), the Practice will not, directly or indirectly, own, manage, operate, join, control,
finance or participate in, or participate in the ownership, management, operation, control or financing of, or be connected as an owner,
investor, partner, joint venturer, director, limited liability company manager, employee, independent contractor, consultant or other
agent of, any person or enterprise that provides any professional practice management services similar to the Management Services anywhere
in or with respect to the geographic area within 20 miles of any Medical Office or with respect to which the Practice has taken concrete
steps to expand. Nothing in this Section prohibits the Practice or the Clinical Professionals from providing professional
clinical services. “Restricted Period” shall mean the shorter of (i) the period from the date of this Agreement
until the second anniversary of the termination of this Agreement or (ii) the longest time period after the date of this Agreement
that is permitted by applicable Law if two years after the termination of this Agreement is not permitted. Notwithstanding anything to
the contrary herein, this Section is intended to apply to the Practice only and is not intended to supersede, amend or modify the
terms of any non- compete restrictions set forth in any agreement between any equityholder of the Practice and Management or an affiliate
of Management.

 

    14

     

    

 

14.4            Covenant
Not to Solicit. Until the second anniversary of the expiration or termination of this Agreement, Practice will not, directly or indirectly:

 

(a)            solicit
or induce or attempt to solicit or induce (including by recruiting, interviewing or identifying or targeting as a candidate for recruitment)
any member of the board of directors or equivalent governing body, officer or personnel (whether engaged as an employee or independent
contractor) of Management (excluding such Practice) who is acting in such capacity or acted in such capacity at any time within the 12-month
period immediately precedingthe date of such solicitation, inducement or attempt (a “Business Associate”) to terminate,
restrictor hinder such Business Associate’s association with any Management entity or affiliate or interfere in any way with the
relationship between such Business Associate and any Managemententity or affiliate; provided, however, that after the termination
or expiration of this Agreement, general solicitations published in a journal, newspaper or other publication or posted on an internetjob
site and not specifically directed toward Business Associates will not constitute a breach of thecovenants in this Section,

 

(b)            hire
or otherwise retain the services of any Business Associate as equityholder, director, limited liability company manager, partner, officer,
employee, independent contractor, licensee, consultant, advisor, agent or in any other capacity, or attempt or assist anyone else to
do so, or

 

(c)            interfere
with the relationship between any Management entity or affiliate and any person who is a partner, joint venturer, investor, lender, consultant,
agent or other person having a business relationship with the Management entity or affiliate, or attempt or assist anyone else to do
so.

 

Notwithstanding anything to the contrary herein, this Section is
intended to apply to the Practice only and is not intended to supersede, amend or modify the terms of any non-solicitation restrictions
set forth in any agreement between any equityholder of the Practice and Management or an affiliate of Management.

 

14.5            Non-Disparagement.
After the date of this Agreement, neither party will directly or indirectly, make any disparaging, derogatory, negative or knowingly
false statement about the other party, affiliate, subsidiary or any of their respective directors, managers, officers, equityholders,
employees, agents, successors and permitted assigns, or any of their respective businesses, operations, financial condition or prospects,
except as required by applicable law.

 

14.6            Equitable
Relief. Each party acknowledges and agrees that (i) the restrictive covenants contained in this Section and the territorial,
time, activity and other limitations set forth herein are commercially reasonable and do not impose a greater restraint than is necessary
to protect the goodwill and legitimate business interests of the other party, its affiliates, subsidiaries and its businesses. Each party
acknowledges and agrees that a breach of this Section 14 will result in irreparable harm to the other party and the other
party cannot be reasonably or adequately compensated in damages, and therefore, the other party shall be entitled to equitable remedies,
including, but not limited to, injunctive relief, to prevent a breach and to secure enforcement thereof in addition to any other
relief or award to which such party may be entitled.

 

    15

     

    

 

		15.	FORCE MAJEURE.

 

Notwithstanding
any provision contained herein to the contrary, neither party shall be deemed to be in default hereunder for failing to perform or provide
the services or obligations pursuant to this Agreement if such failure is the result of any labor dispute, act of God, inability to obtain
labor or materials, governmental restrictions or any other event which is beyond the reasonable control of such party; provided, however,
that if such event continues for a period in excess of thirty (30) days, either party shall have the right to terminate this Agreement
by providing the other party with a written notice of its desire to terminate this Agreement at least thirty (30) days prior to the effective
date of any such termination.

 

		16.	DISPUTE RESOLUTION.

 

In the event that
any material controversy or dispute arises between the parties hereto with respect to the enforcement or interpretation of this Agreement,
or of any specific terms and provisions set forth herein, the parties shall use their best efforts and due diligence to reach an agreement
for the resolution of such controversy or dispute. In the event that the parties are unable to resolve any such controversy or dispute
within thirty (30) days, such controversy or dispute shall be submitted to a disinterested third party mediator chosen by the parties
for nonbinding mediation prior to either party’s instituting any formal legal action at law. However, the foregoingprovisions of
this Section 16 shall not be interpreted to restrict either party’s right to pursue equitable relief from a court of
competent jurisdiction at any time or to terminate this Agreement in accordance with Section 11 above.

 

		17.	GOVERNING LAW.

 

This Agreement
shall be governed by and interpreted under the laws of the State of California, except for clinical matters relating to the corporate
practice of law and other restrictions, which shall be governed by the law of the applicable State. Any legal action, suit or proceeding
brought by a party that in any way arises out of this Agreement (“Proceeding”) must be litigated exclusively in the
state or federal courts of California (the “Identified Courts”). Each party hereby irrevocably and unconditionally:
(i) submits to the jurisdiction of the Identified Courts for any Proceeding; (ii) shall not commence any Proceeding, except
in the Identified Courts; (iii) waives, and shall not plead or make, any objection to the venue of any Proceeding in the Identified
Courts; (iv) waives, and shall not plead or make, any claim that any Proceeding brought in the Identified Courts has been brought
in an improper or otherwise inconvenient forum; and (v) waives, and shall not plead or make, any claim that the Identified Courts
lack personal jurisdiction over it.

 

		18.	ENTIRE AGREEMENT; BINDING EFFECT; BENEFIT.

 

This Agreement
and the exhibits attached hereto constitute the entire agreement between the parties with respect to the subject matter hereof and supersedes
all prior documents, representations and understandings of the parties which may relate to the subject matter of this Agreement. No other
understanding, oral or otherwise, regarding the subject matter of this Agreement shall bind either party. This Agreement will inure to
the benefit of and bind the parties and their respective successors and permitted assigns. Nothing in this Agreement, express or implied,
may be construed to give any Person other than the parties and their respective successors and permitted assigns any right, remedy, claim,
obligation or liability arising from or related to this Agreement. This Agreement and all of its provisions and conditions are for the
sole and exclusive benefit of the parties and their respective successors and permitted assigns.

 

    16

     

    

 

		19.	AMENDMENT.

 

No modification, amendment or addition
to this Agreement, nor waiver of any of its provisions, shall be valid or enforceable unless in writing and signed by both parties.

 

		20.	HEADINGS.

 

The headings set
forth herein are for the purpose of convenient reference only, and shall have no bearing whatsoever on the interpretation of this Agreement.

 

		21.	NOTICES.

 

All notices, requests,
demands or other communications hereunder must be in writing and must be given and shall be deemed to have been given upon receipt if
delivered by Federal Express, facsimile or email, on the date of delivery if delivered in person, or three (3) days after mailing
if sent by certified or registered mail with first-class postage prepaid, as follows:

 

	If
    to Practice:	 	The Oncology Institute CA, a Professional Corporation

    18000 Studebaker Road, #800

    Cerritos, CA 90703 

    c/o: Yale Podnos, M.D. 

    Attention: President

    Email:

 

	 	 	with a copy (not
    constituting notice) to:
	 	 	Greenberg Glusker LLP

    2049 Century Park East, Suite 2600 Los Angeles,
    CA 90067

    Attention: Andrew M. Apfelberg

    Email:

	 	 	 
	If to Management:	 	TOI Management, LLC 

    18000 Studebaker Road, #800

    Cerritos, CA 90703 

    Attention: Mark 

    Hueppelsheuser, General Counsel

    Email:

 

    17

     

    

 

	 	 	and
	 	 	 
	 	 	Havencrest Healthcare Partners, L.P.
	 	 	5221 N. O’Connor Blvd. East Tower, Suite 1200 

    Irving, Texas 75039
	 	 	Attention: Matt D. Shofner 

    Email:
	 	 	 
	 	 	and
	 	 	 
	 	 	M33 Growth
	 	 	888 Boylston Street, Suite 500
	 	 	Boston, MA 02199 

    Attn: Gabriel Ling
	 	 	Email:
	 	 	 
	 	 	and
	 	 	 
	 	 	ROCA Partners LLC
	 	 	9460 Wilshire Blvd., Suite 850 

    Beverly Hills, CA 90212
	 	 	Attn: Ravi Sarin
	 	 	Email:
	 	 	 
	 	 	with a copy (not constituting notice) to: 

    

    McDermott Will & Emery LLP
	 	 	333 Avenue of the Americas, Suite 4500 

    Miami, Florida 33131
	 	 	Attention: Alexander Clavero 

    Email:

 

or to such other person(s) or address(es) as may be
designated by the parties in accordance with the provisions of this Section 21.

 

		22.	WAIVER.

 

Any waiver of
any provision hereof shall not be effective unless expressly made in writing executed by the party to be charged. The failure of any
party to insist on performance of any of the terms or conditions of this Agreement shall not be construed as a waiver or relinquishment
ofany rights granted hereunder or of the future performance of any such term, covenant or condition,and the obligations of the parties
with respect thereto shall continue in full force and effect.

 

    18

     

    

 

		23.	NO THIRD PARTY BENEFICIARY.

 

None of the provisions contained in
this Agreement is intended by the parties, nor shall any be deemed, to confer any benefit on any person not a party to this Agreement.

 

		24.	COUNTERPARTS.

 

This Agreement
may be executed in two or more counterparts, all of which shall, in the aggregate, be considered one and the same instrument. The parties
may deliver executed signature pages to this Agreement by facsimile or e-mail transmission.

 

		25.	SEVERABILITY.

 

If any provision
or portion of any provision herein is held to be unenforceable or invalid by a court of competent jurisdiction, the validity and enforceability
of the remaining provisions of this Agreement shall not be affected thereby. If any court of competent jurisdiction holds the geographic
or temporal scope of any restrictive covenant contained in this Agreement invalid or unenforceable, then such restrictive covenant will
be construed as a series of parallel restrictive covenants and the geographic or temporal scope of each such restrictive covenant will
be deemed modified (including by application of any “blue pencil” doctrine under applicable Law) to the minimum extent necessary
to render such restrictive covenant valid and enforceable.

 

		26.	ADDITIONAL DOCUMENTS.

 

Each of the parties
hereto agrees to execute any document or documents that may be requested from time to time by the other party to implement or complete
such party’s obligations pursuant to this Agreement and to otherwise cooperate fully with such other party in connection with the
performance of such party’s obligations under this Agreement.

 

		27.	EXCLUSION

 

Each party warrants
that neither it, nor any of its employees or agents, is currently listed by a Federal agency as excluded, debarred, or otherwise ineligible
for participation in any Federal health care program. Each party agrees that it will not employ, contract with, or otherwise use the
service of any individual whom it knows or should have known, after reasonable inquiry (a) has been convicted of a criminal offense
related to health care (unless the individual has been reinstated to participation in Medicare and all other Federal health care programs
after being excluded because of the conviction), or (b) is currently listed by a Federal agency as excluded, debarred, or otherwise
ineligible for participation in any Federal health care program and further agrees that it will immediately notify the other party in
the event that it, or any person in its employ, has been excluded, debarred, or has otherwise become ineligible for participation in
any Federal health care program. Each party agrees to continue to make reasonable inquiry regarding the status of its employees and independent
contractors on a regular basis, to the extent required by law, byreviewing applicable exclusion lists.

 

		28.	FEDERAL ACCESS TO RECORDS

 

To the extent
applicable under Section 1861(v)(1)(i) of the Social Security Act, as amended, Management agrees that, upon request made in
accordance with applicable law and regulations, the Comptroller General of the United States, the United States Department of Health
and Human Services and the duly authorized representatives of the foregoing shall be given access by Management to the following records
from the date of the Agreement until the expiration of four (4) years after the furnishing of the services under the Agreement:
the Agreement, all books, documents and records of Management or its subcontractors that are necessary to verify the nature and extent
of the costs to Practice of services rendered under this Agreement. In the event that any request for the books, documents and records
of Management or its subcontractors is made pursuant to this Section, Management shall promptly give notice of such request to Practice
and shall promptly grant Practice access to each book, document and record made available to one or more of the persons and agencies
listed above for Practice to review and copy.

 

[Remainder of the page is blank. Signature
pages follow.]

 

    19

     

    

 

IN
WITNESS WHEREOF, the parties have executed this Agreement effective as of the date first written above.

 

	MANAGEMENT:	 	PRACTICE:
	 	 	 
	TOI
    Management, LLC, 

    a Delaware limited liability company	 	The Oncology Institute CA,
    a Professional Corporation, 

    a California professional corporation
	 	 	 
	By:	/s/ Brad Hively	 	By:	/s/
    Yale Podnos
	Print:
    Brad Hively	 	Print: Yale Podnos, M.D. 
	Title: Chief Executive Officer	 	Title: President

 

    20

     

    

 

 

EXHIBIT A

 

MEDICAL OFFICES

 

Applicable
States: Arizona, California, and Nevada.

 

See attached for list of Medical Offices.

 

     

     

    

 

EXHIBIT B

 

SUBSIDIARIES

 

	 	Subsidiary	Activity
	2.	Innovative Clinical Research Institute, LLC	
    Facilitation and administration of clinical trials as a Site
    Management

    Organization

 

    B1-1

     

    

 

EXHIBIT C

OTHER SERVICES

 

[To be listed.]

 

    B2-2

     

    

 

EXHIBIT D

MANAGEMENT FEE

 

(1)            Management
Fee: In consideration of the Management Services, the Practice will pay Management a monthly fee [***]. The monthly payment shall be payable no later than the 15th day of
the month following the month in which it is due.

 

[***]

 

“Gross Revenue”
shall be defined as total revenues [***].

 

(2)            Adjustment.
The parties recognize that the Practice and its Subsidiaries may change in size and scope over the term of this Agreement, which may cause
the Management Fee to no longer reflect the fair market value of the Management Services provided pursuant to this Agreement; accordingly,
the parties will review the Management Fee [***].

 

(3)            Bonus.
At least annually, the Practice shall determine an appropriate bonus (if any) to be paid to Management [***].

 

    B3-3

     

    

 

EXHIBIT E

 

HIPAA

BUSINESS ASSOCIATE ADDENDUM

 

		I.	GENERAL PROVISIONS

 

Section 1.1.
Status of Parties Under HIPAA. The parties acknowledge and agree that The Oncology Institute CA, a Professional Corporation,
a California professional corporation (“Covered Entity”) is a “Covered Entity” and TOI Management, LLC, a Delaware
limited liability company (“Company”) is a “business associate” of CoveredEntity when Company receives, maintains,
transmits, uses or discloses Protected Health Information on behalf of Covered Entity.

 

Section 1.2.
Effect. To the extent that Company receives Protected Health Information from or on behalf of Covered Entity (“PHI”)
to perform Business Associate activities, the terms and provisions of this Addendum shall supersede any other conflicting orinconsistent
terms and provisions in this Agreement to the extent of such conflict or inconsistency.

 

Section 1.3.
Capitalized Terms. Capitalized terms used herein without definition in this Agreement (including this Addendum) shall
have the respective meanings assigned to such terms by the administrative simplification section of the Health Insurance Portability and
Accountability Act of 1996 and its implementing regulations as amended by HITECH (as defined in Section 1.5 of this Addendum) (collectively,
 “HIPAA”).

 

Section 1.4.
No Third Party Beneficiaries. The parties have not created and do not intend to create by this Agreement any third party
rights, including, but not limited to, third party rights for Covered Entity’s patients.

 

Section 1.5.
Amendments. The parties acknowledge and agree that the Health Information Technology for Economic and Clinical Health
Act and its implementing regulations (collectively, “HITECH”) impose new requirements with respect to privacy, security and
breach notification and contemplates that such requirements shall be implemented by regulations to be adopted by HHS. The HITECH provisions
applicable to business associates will be collectively referred to as the “HITECH BA Provisions.” The provisions of HITECH
and the HITECH BA Provisions are hereby incorporated by reference into this Agreement as if set forth in this Agreement in their entirety
effective on the later of the effective date of this Agreement or such subsequent effective date specified in HITECH.

 

Section 1.6.
Regulatory References. A reference in this Addendum to a section in HIPAA means the section as it may be amended from
time-to-time.

 

		II.	OBLIGATIONS OF THE COMPANY

 

Section 2.1.
Use and Disclosure of PHI. Company may use and disclose PHI as permitted or required under this Agreement (including
this Addendum) or as Required by Law, but shall not otherwise use or disclose any PHI. Company shall not use or disclose PHI received
from Covered Entity in any manner that would constitute a violation of HIPAA if so used or disclosed by Covered Entity (except as set
forth in Sections 2.1(a), (b) and (c) of this Addendum). To the extent Company carries out any of Covered
Entity’s obligations under the HIPAA Privacy Rule, Company shall comply with the requirements of the HIPAA PrivacyRule that
apply to Covered Entity in the performance of such obligations. Without limiting the generality of the foregoing, Company is permitted
to use or disclose PHI as set forth below:

 

    B4-4

     

    

 

(a)            Company
may use PHI internally for Company’s proper management and administration or to carry out its legal responsibilities.

 

(b)            Company
may disclose PHI to a third party for Company’s proper management and administration, provided that the disclosure is Required by
Law or Company obtains reasonable assurances from the third party to whom the PHI is to be disclosed that the third party will (1) protect
the confidentially of the PHI, (2) only use or further disclose the PHI as Required by Law or for the purpose for which the PHI was
disclosed to the third party and (3) notify Company of any instances of which the person is aware in which the confidentiality of
the PHI has been breached.

 

(c)            Company
may use PHI to provide Data Aggregation services relating to the Health Care Operations of Covered Entity if required or permitted under
this Agreement.

 

(d)            Business
Associate may use PHI to create de-identified health information in accordance with the HIPAA de-identification requirements. Business
Associate may disclose de-identified health information for any purpose permitted by law.

 

Section 2.2.
Safeguards. Company shall use appropriate safeguards to prevent the use or disclosure of PHI other than as permitted
or required by this Addendum. In addition, Company shall implement Administrative Safeguards, Physical Safeguards and Technical Safeguards
that reasonably and appropriately protect the Confidentiality, Integrity and Availability of PHI transmitted or maintained in Electronic
Media (“EPHI”) that it creates, receives, maintains or transmits on behalf of Covered Entity. Company shall comply with the
HIPAA Security Rule with respect to EPHI.

 

Section 2.3.
Minimum Necessary Standard. To the extent required by the “minimum necessary” requirements of HIPAA, Company
shall only request, use and disclose the minimum amount of PHI necessary to accomplish the purpose of the request, use or disclosure.

 

Section 2.4.
Mitigation. Company shall take reasonable steps to mitigate, to the extent practicable, any harmful effect (that is
known to Company) of a use or disclosure of PHI by Company in violation of this Addendum.

 

Section 2.5.  Subcontractors. Company shall enter into a written agreement meeting the requirements of 45 C.F.R. §§ 164.504(e) and
164.314(a)(2) with each Subcontractor (including, without limitation, a Subcontractor that is an agent under applicable law) that
creates, receives, maintains or transmits PHI on behalf of Company. Company shall ensure that the written agreement with each Subcontractor
obligates the Subcontractor to comply with restrictions and conditions that are at least as restrictive as the restrictions and conditions
that apply to Company under this Agreement.

 

    B5-5

     

    

 

Section 2.6.     Reporting
Requirements.

 

(a)            If
Company becomes aware of a use or disclosure of PHI in violation of this Agreement by Company or a third party to which Company disclosed
PHI, Company shall report the use or disclosure to Covered Entity without unreasonable delay, and in no event three (3) business
days of discovering such unauthorized disclosure.

 

(b)            Company
shall report any Security Incident involving EPHI of which it becomes aware in the following manner: (a) any actual, successful Security
Incident will be reported to Covered Entity in writing without unreasonable delay, and (b) any attempted, unsuccessful Security Incident
of which Company becomes aware will be reported toCovered Entity orally or in writing on a reasonable basis, as requested by Covered Entity.
Ifthe HIPAA security regulations are amended to remove the requirement to report unsuccessful attempts at unauthorized access, the requirement
hereunder to report such unsuccessful attempts will no longer apply as of the effective date of the amendment.

 

(c)            Company
shall, following the discovery of a Breach of Unsecured PHI, notify Covered Entity of the Breach in accordance with 45 C.F.R. § 164.410
without unreasonable delay and in no case later than three (3) days after discovery of the Breach.

 

Section 2.7.
Access to Information. Within 15 business days of a request by Covered Entity for access to PHI about an Individual
contained in any Designated Record Setof Covered Entity maintained by Company, Company shall make available to Covered Entitysuch PHI
for so long as Company maintains such information in the Designated Record Set. If Company receives a request for access to PHI directly
from an Individual, Company shall forward such request to Covered Entity within ten business days. Covered Entity shall have the sole
responsibility to make decisions regarding whether to approve a request for access toPHI.

 

Section 2.8.
Availability of PHI for Amendment. Within 15 business days of receipt of a request from Covered Entity for the amendment
of an Individual’s PHI containedin any Designated Record Set of Covered Entity maintained by Company, Company shall provide such
information to Covered Entity for amendment and incorporate any such amendments in the PHI (for so long as Company maintain such information
in the DesignatedRecord Set) as required by 45 C.F.R. § 164.526. If Company receives a request for amendment to PHI directly from
an Individual, Company shall forward such request to Covered Entity within ten business days. Covered Entity shall have the sole responsibility
tomake decisions regarding whether to approve a request for an amendment to PHI.

 

Section 2.9.
Accounting of Disclosures. Within 15 business days of notice by Covered Entity to Company that it has received a request
for an accounting of disclosures of PHI (other than disclosures to which an exception to the accounting requirement applies), Company
shall make available to Covered Entity such information as is in Company’s possession and is required for Covered Entity to make
the accounting required by 45 C.F.R. § 164.528. If Company receives a request for an accounting directly from an Individual, Company
shall forward such request to Covered Entity within ten business days. Covered Entity shall have the sole responsibility to provide an
accounting of disclosures to .

 

    B6-6

     

    

 

Section 2.10.
Availability of Books and Records. Company shall make their internal practices, books and records relating to the use
and disclosure of PHI received from,or created or received by Company on behalf of, Covered Entity available to the Secretary forpurposes
of determining Covered Entity’s and Company’s compliance with HIPAA.

 

		III.	OBLIGATIONS OF THE COVERED ENTITY

 

Section 3.1.
Permissible Requests. Covered Entity shall not request Company to use or disclose PHI in any manner that would not be
permissible under HIPAA if done directlyby Covered Entity (except as provided in Sections 2.1(a), (b) and (c) of
this Addendum).

 

Section 3.2.
Minimum Necessary PHI. When Covered Entity discloses PHI to Company, Company shall provide the minimum amount of PHI
necessary for the accomplishment of Company’s purpose.

 

Section 3.3.
Permissions; Restrictions. Covered Entity warrants that it has obtained and will obtain any consents, authorizations
and/or other legal permissions requiredunder HIPAA and other applicable law for the disclosure of PHI to Company. Covered Entityshall
notify Company of any changes in, or revocation of, the permission by an Individual touse or disclose his or her PHI, to the extent that
such changes may affect Company’s use or disclosure of PHI. Covered Entity shall not agree to any restriction on the use or disclosure
of Practice Data under 45 CFR § 164.522 that restricts Company’s use or disclosure of PHI under this Agreement unless Company
grants its written consent, which consent shall not be unreasonably withheld.

 

Section 3.4.
Notice of Privacy Practices. Except as required by HIPAA or other applicable law, with Company’s consent or as
set forth in the Services Agreement, Covered Entity shall not include any limitation in the Covered Entity’s notice of privacy practices
that limits Company’s use or disclosure of PHI under this Agreement.

 

		IV.	TERMINATION OF THIS AGREEMENT

 

Section 4.1.
Termination Upon Breach of this Addendum. Any other provision of this Agreement notwithstanding, either party (the “Non-Breaching
Party”) may terminate this Agreement upon 30 days advance written notice to the other party (the “Breaching Party”)in
the event that the Breaching Party materially breaches this Addendum and such breach is not cured to the reasonable satisfaction of the
Non-Breaching Party within such 30-day period; provided, however, that in the event that termination of this Agreement is not feasible,
in the Non-Breaching Party’s sole discretion, the Non-Breaching Party has the right to report the breach to the Secretary.

 

Section 4.2.
Return or Destruction of PHI upon Termination. Upon expiration or earlier termination of this Agreement, Company shall
either return or destroy all PHI received from Covered Entity or created or received by Company on behalf of Covered Entity and which
Company still maintains in any form. Notwithstanding the foregoing, to the extent that Company reasonably determines that it is not feasible
to return or destroy such PHI, the terms and provisions of this Addendum shall survive termination of this Agreement and such PHI shall
be used or disclosed solely for such purpose or purposes which prevented the return or destruction of such PHI.

 

		V.	GOVERNING LAW AND VENUE

 

The terms of this Addendum shall be
governed by the term of the Agreement as it relates to governing law and venue.

 

    B7-7

     

    

 

EXECUTION VERSION

 

FIRST AMENDMENT TO AMENDED
AND RESTATED MANAGEMENT SERVICES AGREEMENT

 

This FIRST
AMENDMENT TO THE AMENDED AND RESTAETD MANAGEMENT SERVICES AGREEMENT (this “Amendment”)
is entered into as of the date this Amendment is fully executed, by and between TOI Management, LLC, a Delaware limited liability company
(“Management”) and The Oncology Institute CA, a Professional Corporation (formerly known as Richy Agajanian, M.D., a Professional
Corporation), a California professional corporation (the “Practice”), for itself and on behalf of its subsidiaries (whether
currently operating or hereafter created or acquired) (collectively, the “Subsidiaries”). Management and the Practice are
each referred to herein as a “Party” and collectively as the “Parties.” Capitalized terms that are used but not
defined herein will have the meanings ascribed to them in the Agreement.

 

RECITALS

 

WHEREAS,
the Parties entered into that certain Amended and Restated Management Services Agreement dated January 12, 2021 (the “Agreement”);

 

WHEREAS,
the Parties desire to amend the Agreement as set forth herein for purposes of clarifying the terms of the Agreement.

 

NOW, THEREFORE,
in consideration of the mutual promises and covenants contained in this Amendment, and other good and valuable consideration, the
receipt and adequacy of which are hereby acknowledged, the Parties agree as follows:

 

AGREEMENT

 

		1.	Amendments. The Parties restate and amend the Agreement as follows:

 

		a.	Section 3.3 of the Agreement is deleted in its entirety and amended to read as follows:

 

3.3             
Hours of Operation. The hours of operation of the Medical Offices shall be Monday through Friday (or as otherwise determined
by Practice in consultation with Management), excluding holidays, during such hours as may be determined by Practice in consultation with
Management, as well as such additional weekend and holiday hours as may be determined by Practice in consultation with Management. The
Subsidiaries shall operate at such times as are determined by Practice in consultation with Management.

 

     

     

    

 

		b.	Section 3.4 of the Agreement is deleted in its entirety and amended to read as follows:

 

3.4             
Clinical Professionals. Practice and Subsidiaries (as applicable) will employ or engage all clinical professionals, including
all nurse practitioners, nurses and other allied health professionals (the “Clinical Professionals”), necessary to
conduct, manage and operate in a proper and efficient manner the Practice at the Medical Offices. Such professionals will be engaged or
employed pursuant to written agreements developed by Management in consultation with Practice, subject to final approval by Practice.

 

		c.	Section 3.6 of the Agreement is deleted in its entirety and amended to read as follows:

 

3.6 Managed Care Agreements.
Practice shall consider in good faith all managed care agreements identified by Management and presented to Practice.

 

		d.	Section 5.2(a) of the Agreement is deleted in its entirety and amended to read as follows:

 

		5.2	Equipment, Fixtures, Furniture and Improvements.

 

(a)               
Management shall furnish for use by Practice and Subsidiaries, as applicable, certain medical equipment, office equipment, fixtures,
furniture and leasehold improvements (collectively, the “Equipment”) deemed by Management to be reasonably necessary
for the proper and efficient operation of the Medical Offices, the Practice and the Subsidiaries, subject to approval by Practice. Management
and Practice may mutually agree to the selection of any replacement or additional equipment. Any such replacement or additional equipment,
if any, shall thereafter be deemed to be the Equipment for purposes of this Agreement.

 

		e.	Section 5.4 of the Agreement is deleted in its entirety and amended to read as follows:

 

5.4 Supplies. Management
shall furnish such supplies as may be deemed reasonably necessary by Management for the proper and efficient operation of the Practice
and the Subsidiaries, subject to approval by Practice, including, but not limited to, stationery, statement forms or invoices, office
supplies, copier paper and medical supplies (including pharmaceuticals in accordance with applicable federal and state law).

 

		2.	Remaining Provisions. Except as amended hereby, the terms of the Agreement remain in full
force and effect.

 

     

     

    

 

		3.	Governing Law. This Amendment shall be governed by the substantive
laws of the State of California without giving effect to conflict of laws principles.

 

		4.	Counterparts. This Amendment may be executed in two or more counterparts,
each of which shall be deemed to be an original and all of which taken together shall constitute one and the same instrument.

 

[Signature
Page Follows]

 

     

     

    

 

IN WITNESS WHEREOF, the Parties
hereto have caused this Third Amendment to be executed as of the dates set forth below.

 

	PRACTICE:	The
    Oncology Institute CA, a Professional Corporation

 

		By:	/s/
                                            Yale Podnos
	 	 	Name: Yale Podnos
	 	 	Title: President
	 	 	Date: 6/24/2021
	 	 	 
	MANAGEMENT:	TOI Management, LLC
	 	 	 
		By:	/s/
                                            Brad Hively
	 	 	Name: Brad Hively
	 	 	Title: CEO
	 	 	Date: 6/24/2021Exhibit 10.7

 

TOI PARENT, INC.

 

2019 NON-QUALIFIED STOCK OPTION PLAN

 

    

     

    

 

TABLE OF CONTENTS

 

TOI PARENT, INC.

 

2019 NON-QUALIFIED STOCK OPTION
PLAN

 

	 	 	Page
	 	 	 
	1.	PURPOSE	1
	 	 	 
	2.	ADMINISTRATION OF THE PLAN	1
	 	 	 
	3.	OPTION SHARES	2
	 	 	 
	4.	AUTHORITY TO GRANT OPTIONS	3
	 	 	 
	5.	OPTION AGREEMENTS	3
	 	 	 
	6.	ELIGIBILITY	3
	 	 	 
	7.	EXERCISE PRICE	3
	 	 	 
	8.	DURATION AND EXERCISABILITY OF OPTIONS	3
	 	 	 
	9.	RESTRICTIONS ON EXERCISE OF OPTIONS	3
	 	 	 
	10.	EXERCISE OF OPTIONS	4
	 	 	 
	11.	NON-TRANSFERABILITY OF OPTIONS	4
	 	 	 
	12.	TERMINATION OF EMPLOYMENT OR INVOLVEMENT OF THE OPTIONEE WITH THE COMPANY	5
	 	 	 
	13.	REQUIREMENTS OF LAW	5
	 	 	 
	14.	NO RIGHTS AS STOCKHOLDER	6
	 	 	 
	15.	NO EMPLOYMENT OBLIGATION	6
	 	 	 
	16.	CHANGES IN THE COMPANY’S CAPITAL STRUCTURE	6
	 	 	 
	17.	DEFINITIONS	8
	 	 	 
	18.	AMENDMENT OR TERMINATION OF PLAN AND OPTIONS	10

 

    -i-

     

    

 

TABLE OF CONTENTS

(continued)

 

	 	 	Page
	 	 	 
	19.	CERTAIN RIGHTS OF THE COMPANY	11
	 	 	 
	20.	WITHHOLDING TAXES	11
	 	 	 
	21.	GOVERNING LAW; CONSTRUCTION	11
	 	 	 
	22.	EFFECTIVE DATE OF THE PLAN	11

 

    -ii-

     

    

 

2019 NON-QUALIFIED STOCK OPTION PLAN

 

TOI Parent, Inc. hereby
adopts in its entirety the TOI Parent, Inc. 2019 Non-Qualified Stock Option Plan (the “Plan”), as of January 2, 2019
(“Plan Adoption Date”). Capitalized terms used but otherwise not defined elsewhere in the Plan are defined in Section
17.

 

		1.	PURPOSE

 

The purpose
of the Plan is to provide an incentive to directors, consultants, advisors and key employees of TOI Parent, Inc., a Delaware corporation
(the “Company”), and its Subsidiaries to continue their association with the Company and its Subsidiaries by providing
opportunities for such persons to participate in the ownership of the Company and in its further growth, and to offer an additional inducement
in obtaining the services of such persons. The Plan provides for the grant of options (the “Options”) to acquire Stock
that are not intended to qualify as “incentive stock options” under the Internal Revenue Code of 1986, as amended (the “Code”).
Capitalized terms not defined elsewhere in the document are defined in Section 17.

 

		2.	ADMINISTRATION OF THE PLAN

 

(a)               
The Plan shall be administered by a committee (the “Committee”) consisting of the Board or such individual directors
who shall from time to time be designated by the Board. Each member of the Committee shall, at any time that the Company has a class of
equity securities registered under Section 12 of the Exchange Act, be a “disinterested person” within the meaning of Rule
16b-3 under the Exchange Act and an “outside director” within the meaning of Section 162(m) of the Code.

 

(b)              
The Committee shall, from time to time, report to the Board the names of employees or other persons to whom Options are granted,
the number of shares covered by each Option and the terms and conditions of each such Option.

 

    -1-

     

    

 

(c)                The
Committee shall have the authority, in its sole and absolute discretion, to adopt, amend and rescind such rules and regulations as,
in its opinion, may be advisable in the administration of the Plan, and to construe and interpret the Plan, the rules and
regulations, and the instruments evidencing Options granted under the Plan and to make all other determinations deemed necessary or
advisable for the administration of the Plan. The Committee may correct any defect, supply any omission or reconcile any
inconsistency in the Plan or any Option in the manner and to the extent it deems necessary to carry out the intent of the Plan
including, but not limited to, the right to determine: the persons who shall be granted Options; the times when an Option shall be
granted; whether or not modifications are necessary in order for the Options to comply with requirements of Code Section 409A; the
number of shares of Stock to be subject to each Option; the term of each Option; the date each Option shall vest and become
exercisable; whether an Option shall be exercisable in whole, in part or in installments and, if in installments, the number of
shares of Stock to be subject to each installment, whether the installments shall be cumulative, the date each installment shall
become exercisable and the term of each installment; whether to accelerate the date of exercise of any Option or installment;
whether shares of Stock may be issued upon the exercise of an Option as partly paid and, if so, the dates when future installments
of the exercise price shall become due and the amounts of such installments; the exercise price of each Option; the form of payment
of the exercise price; whether to restrict the sale or other disposition of the shares of Stock acquired upon the exercise of an
Option and, if so, whether and under what conditions to waive any such restriction; whether and under what conditions to subject all
or a portion of the grant or exercise of an Option to the fulfillment of certain restrictions or contingencies as specified in the
Option Agreement, including without limitation, restrictions or contingencies relating to entering into a covenant not to compete
with the Company or its Subsidiaries and affiliates, to financial objectives for the Company or its Subsidiaries and affiliates or a
division of any of the foregoing, a product line or other category, and/or to the period of continued employment of the Optionee
with the Company or its Subsidiaries and affiliates, and to determine, in each case, whether such limitations, restrictions or
contingencies have been met; whether an Optionee is disabled; the amount, if any, necessary to satisfy the obligation of the Company
to withhold taxes or other amounts; the fair market value of a share of Stock; and to construe the Option Agreements and the Plan.
Any controversy or claim arising out of or relating to the Plan, any Option granted under the Plan or any Option Agreement shall be
determined unilaterally by the Committee in its sole and absolute discretion. The Committee may correct any defect, supply any
omission or reconcile any inconsistency in the Plan or any Option in the manner and to the extent it deems necessary to carry out
the intent of the Plan. All decisions, determinations and interpretations of the Committee shall be final, binding and conclusive on
all Optionees. No member or former member of the Committee shall be liable for any action, failure to act or determination made in
good faith with respect to the Plan, any Option Agreement or any Option hereunder.

 

(d)              
The Plan is intended to grant non-qualified options that are not deferred compensation within the meaning of Section 409A
of the Code, and it shall be interpreted and administered consistent with this intent. In the event that, after the issuance of an Option
under the Plan, Section 409A of the Code or regulations thereunder are issued or amended, or the Internal Revenue Service or Treasury
Department issues additional guidance interpreting Section 409A of the Code or if for any other reason it is determined by the Committee
that a previously granted Option may not be exempt from or comply with Section 409A of the Code or regulations thereunder, the Committee
may modify the terms of any such previously issued Option to the extent the Committee determines that such modification is necessary to
exempt the option from or cause the Option to comply with the requirements of Section 409A of the Code.

 

		3.	OPTION SHARES

 

Options
may be granted under the Plan to acquire shares of Stock. The total number of shares of Stock for which Options may be granted under the
Plan (the “Option Pool”) shall not exceed, in the aggregate, One Thousand, Three Hundred and Sixty-Four (1,364); provided,
however, such aggregate number of shares shall be subject to adjustment in accordance with the provisions of Section 16.
In the event that any outstanding Option shall expire for any reason or shall terminate or cease to be exercisable by reason of the death
or termination of employment of the Optionee, the surrender of such Option, or any other cause, the shares of Stock allocable to the unexercised
portion of such Option shall be returned to the Option Pool and shall again become available for the granting of Options under the Plan.

 

    -2-

     

    

 

		4.	AUTHORITY TO GRANT OPTIONS

 

The Committee
may from time to time in its sole discretion grant to such eligible directors, employees or other persons as it shall determine an Option
or Options to buy a stated number of shares of Stock under the terms and conditions of the Plan. Subject only to any applicable limitations
set forth elsewhere in the Plan, the number of shares of Stock to be covered by any Option shall be as determined by the Committee.

 

		5.	OPTION AGREEMENTS

 

Each Option
granted hereunder shall be for such number of shares of Stock, and otherwise subject to such terms and conditions, as the Committee shall
determine and specify in a written option agreement (an “Option Agreement”), which may be in the form of the Option
Agreement attached hereto as Exhibit A or such other form not inconsistent with the Plan as the Committee may determine. Each Option
Agreement shall be signed by the Optionee and by a duly authorized officer of the Company.

 

		6.	ELIGIBILITY

 

Employees and
directors of the Company and its Subsidiaries and other individuals, whether or not employees, who render services to the Company or a
Subsidiary, and who have contributed or may be expected to contribute materially to the success of the Company or a Subsidiary shall be
eligible to be granted Options under the Plan.

 

		7.	EXERCISE PRICE

 

The exercise
price of each Option shall be determined by the Committee, in its sole discretion, and shall be set forth in the applicable Option Agreement
but in no event shall the exercise price be less than the fair market value of a share of Stock on the date of grant.

 

		8.	DURATION AND EXERCISABILITY OF OPTIONS

 

Subject to Section
12 of the Plan, the duration of any Option shall be established by the Committee and shall be set forth in the Option Agreement, but
no Option shall be exercisable after the expiration of ten (10) years from the date such Option is granted. Options will vest and be exercisable
at such time or times and subject to such terms and conditions as determined by the Committee.

 

		9.	RESTRICTIONS ON EXERCISE OF OPTIONS

 

If an
Optionee has materially breached his or her covenants regarding non-competition, non-solicitation, non-disparagement or
confidentiality in his or her employment agreement, Option Agreement or any other agreement between the Optionee and the Company or
any of its Subsidiaries, then such Optionee cannot exercise such Optionee’s Option until and unless the Committee notifies
such Optionee in writing that such material breach has been cured (if curable) to its satisfaction. In determining if such material
breach has actually occurred and if the restriction on exercise should be removed, the Committee shall consider the facts presented
on behalf of the Company and such Optionee. The decision of the Committee as to such material breach and the extent of any
restriction on exercise shall be final, binding, and conclusive.

 

    -3-

     

    

 

		10.	EXERCISE OF OPTIONS

 

(a)               
Vested Options may be exercised by the delivery of (i) written notice to the Company setting forth the number of shares of Stock
with respect to which the Option is to be exercised, (ii) payment of the exercise price of such shares and any federal, state, or local
taxes required to be withheld with respect to such shares (collectively, the “Exercise Payment”), and (iii) a joinder
agreement in form and substance satisfactory to the Company, pursuant to which the Optionee agrees to be bound by the Stockholders Agreement
and, if applicable, a spousal consent by which the Optionee’s spouse consents and agrees to the terms of the Stockholders Agreement.
The Exercise Payment shall be paid to Company by Optionee in cash, or by certified check payable to the order of the Company, in United
States dollars, or in such other form as may be approved by the Committee in its sole discretion. The exercise notice shall be delivered
in person to the Secretary of the Company or shall be sent by registered mail return receipt requested, to the Secretary of the Company,
in which case delivery shall be deemed made on the date such notice is received.

 

(b)              
As promptly as practicable after the receipt by the Company of (i) written notice from the Optionee setting forth the number of
shares of Stock with respect to which such Option is to be exercised, (ii) payment of the Exercise Payment for such shares, and (iii)
execution and delivery of any joinder agreement necessary for the Optionee and, if applicable his or her spouse, to become a party to,
or to consent to, as applicable, the Stockholders Agreement, the Company shall cause to be delivered to such Optionee certificates representing
the number of paid-up, non-assessable shares with respect to which such Option has been so exercised.

 

(c)               
Notwithstanding the foregoing, if an Optionee submits a notice of exercise pending the Company’s determination regarding
whether the Company has Cause to terminate Optionee, then the Company may suspend such exercise until the date of the Company’s
determination. If the Company terminates the Optionee for Cause, then the notice of exercise will be rescinded and the Exercise Payment
returned to the Optionee. If the Company does not terminate the Optionee for Cause, then the notice of exercise will be promptly processed.

 

		11.	NON-TRANSFERABILITY OF OPTIONS

 

Options shall
not be transferable by the Optionee other than by will or the laws of descent and distribution and Options may be exercised, during the
lifetime of the Optionee, only by the Optionee or, in the event of the Optionee’s legal incapacity, by his or her legal representatives.
Except to the extent provided above, Options may not be assigned, transferred, pledged, hypothecated or disposed of in any way (whether
by operation of law or otherwise) and shall not be subject to execution, attachment or similar process, and any attempted assignment,
transfer, pledge, hypothecation or disposition shall be null and void and of no force or effect.

 

    -4-

     

    

 

12.             
TERMINATION OF EMPLOYMENT OR INVOLVEMENT OF THE OPTIONEE WITH THE COMPANY

 

For purposes
of the Plan, a Person serving as an independent contractor or Board member of the Company or any Subsidiary of the Company shall be considered
 “employed” by the Company and termination of such relationship shall be considered termination of such person’s employment.
Unless otherwise specifically provided in an Option Agreement, no portion of an Option will vest after the Optionee’s employment
with the Company and its Subsidiaries is terminated for any reason.

 

Except as may be otherwise set forth in an Option Agreement:

 

(a)               
Each Option shall expire on the earlier of (i) the expiration date specified in the Option Agreement and (ii) ten (10) years from
the date such Option is granted, but shall be subject to earlier termination as provided below in this Section 12 or in the Option
Agreement.

 

(b)              
If an Optionee’s employment with the Company and its Subsidiaries is terminated by reason of death or permanent disability
(as defined in Section 22(e)(3) of the Code, as amended (“Permanent Disability”), then Optionee’s Option shall
expire on the date of such termination of employment with respect to the unvested portion thereof and, with respect to the vested portion
of the Option on the date which is ninety (90) days from the date of such termination of employment.

 

(c)               
If an Optionee’s employment with the Company and its Subsidiaries is terminated by reason of (i) retirement after reaching
age 65, (ii) resignation by Optionee for any reason or (iii) by the Company and its Subsidiaries without Cause, then Optionee’s
Option shall expire on the date of such termination of employment with respect to the unvested portion thereof and, with respect to the
vested portion of the Option on the date which is thirty (30) days from the date of such termination of employment.

 

(d)              
If an Optionee’s employment with the Company and its Subsidiaries is terminated by the Company for Cause, then the Optionee’s
Option shall be deemed to have expired on the day immediately prior to the date of such termination of employment with respect to the
vested and the unvested portion of the Option.

 

		13.	REQUIREMENTS OF LAW

 

The
Company shall not be required to sell or issue any shares of Stock upon the exercise of any Option if the issuance of such shares
shall constitute or result in a violation by the Optionee or the Company of any provisions of any law, statute or regulation of any
government authority. Specifically, in connection with the Securities Act and any applicable state securities or “blue
sky” law (a “Blue Sky Law”), upon exercise of any Option the Company shall not be required to issue such
shares unless the Committee has received evidence satisfactory to it to the effect that such issuance is exempt from the
registration requirements of the Securities Act and the Blue Sky Laws and the holder of such Option will not transfer such shares
except pursuant to a registration statement in effect under the Securities Act and Blue Sky Laws or unless an opinion of counsel
satisfactory to the Company has been received by the Company to the effect that such registration and compliance is not required.
Any such determination by the Committee shall be final, binding and conclusive. The Company shall not be obligated to take any
action in order to cause the exercise of an Option or the issuance of shares of Stock pursuant thereto to comply with any law or
regulations of any governmental authority, including, without limitation, the Securities Act or applicable Blue Sky Law.

 

    -5-

     

    

 

Notwithstanding
any other provision of the Plan to the contrary, the Company may refuse to permit any transfer of shares of Stock or of any Option if
in the opinion of its legal counsel such transfer would violate any federal or state securities laws or subject the Company to liability
thereunder. Any sale, assignment, transfer, pledge or other disposition of shares of Stock received upon exercise of any Option (or any
other shares or securities derived therefrom) or of any Option which is not in accordance with the provisions of this Section 13
shall be void and of no effect and shall not be recognized by the Company.

 

The Committee
may cause any certificate representing shares of Stock acquired upon exercise of an Option (and any other shares or securities derived
therefrom) to bear a legend to the effect that the securities represented by such certificate have not been registered under the Securities
Act, as amended, or any applicable state securities laws, and may not be sold, assigned, transferred, pledged or otherwise disposed of
except in accordance with the Plan and applicable agreements binding the holder and the Company or any of its stockholders.

 

		14.	NO RIGHTS AS STOCKHOLDER

 

No Optionee
shall have any rights as a stockholder with respect to shares covered by his or her Option until the date of issuance of a stock certificate
for such shares. Except as otherwise provided in Section 16, no adjustment for dividends or otherwise shall be made if the record
date therefor is prior to the date of issuance of such certificate to the Optionee.

 

		15.	NO EMPLOYMENT OBLIGATION

 

The granting
of an Option shall not impose upon the Company or any Subsidiary any obligation to employ or continue to employ any Optionee, or to engage
or retain the services of any person, and the right of the Company or any Subsidiary to terminate the employment or services of any person
or reduce the rate of compensation for such person shall not be diminished or affected by reason of the fact that an Option has been granted
to him or her. The existence of an Option shall not be taken into account in determining any damages relating to termination of employment
or services for any reason.

 

		16.	CHANGES IN THE COMPANY’S CAPITAL STRUCTURE

 

(a)                The
existence of outstanding Options shall not affect in any way the right or power of the Company or its stockholders to make or
authorize any or all subdivisions, splits, combinations or consolidations of shares of capital stock of the Company (including, the
Stock) or the payment of a dividend in cash, shares of Stock or other securities of the Company, adjustments, recapitalizations,
reclassifications, reorganizations or other changes in the Company’s capital structure or its business or any merger or
consolidation of the Company or any issuance of bonds, debentures, preferred or preference stock, whether or not convertible into or
exchangeable or exercisable for shares of Stock or other securities, ranking prior to or pari passu with the Stock or
affecting the rights thereof, or warrants, rights or options to acquire the same, or the dissolution or liquidation of the Company
or any sale or transfer of all or any part of its assets or business of the Company or any other corporate act or proceeding,
whether of a similar character or otherwise.

 

    -6-

     

    

 

(b)              
Subject to the provisions of Section 16(d) of the Plan, the number of shares of Stock in the Option Pool (less the number
of shares theretofore delivered upon exercise of Options) and the number of shares of Stock covered by any outstanding Option and the
price per share payable upon exercise thereof (provided that in no event shall the option price be less than the par value of such shares)
shall be appropriately adjusted by the Board in the event that all of the outstanding shares of Stock are changed into or exchanged for
a different number or kind of shares or other securities of the Company or of another corporation by reason of any reorganization, merger,
consolidation, recapitalization, reclassification, stock split, combination of shares of Stock, or dividends payable in Stock. The decision
of the Board as to the adjustment, if any, required by the provisions of this Section 16 shall be final, binding and conclusive
and may provide for the elimination of fractional shares of Stock which might otherwise be subject to Options without payment therefor.

 

(c)               
If the Company merges or consolidates with a wholly-owned Subsidiary for the purpose of reincorporating itself under the laws of
another jurisdiction, the Optionees will be entitled to acquire shares of the stock of the reincorporated company upon the same terms
and conditions as were in effect immediately prior to such reincorporation (unless such reincorporation involves a change in the number
of shares or the capitalization of the Company, in which case proportional adjustments shall be made as provided in Section 16(b)),
and the Plan, unless otherwise rescinded by the Board, will remain the Plan of the reincorporated Company.

 

(d)              
Unless otherwise determined by the Board in its sole discretion and except as otherwise provided in Section 16(c) of the
Plan, if while unexercised Options remain outstanding under the Plan (i) there takes place a Sale of the Company (as defined in the Stockholders
Agreement), or (ii) in other circumstances in which the Board in its sole and absolute discretion deems it appropriate for the provisions
of this paragraph to apply, then the Board may, at its option and in its sole and absolute discretion and without the consent of any Optionee,
take any one or more of the following actions with respect to outstanding Options: (a) accelerate the vesting of any outstanding Options,
(b) cancel any Options in exchange for options to purchase common stock or other equity of any successor company, (c) cancel any Options
in exchange for cash and/or substitute consideration with a value equal to the value of the consideration the Optionee would have received
in connection with such event had the Option been exercised (to the extent it has vested and not been exercised) and no disposition of
the shares so acquired upon such exercise had been made prior to such event, less the Exercise Price payable upon exercise thereof, (d)
provide notice to an Optionee that upon such Sale of the Company or other event all Options granted to such Optionee and not theretofore
exercised shall terminate and be void, in which event the Optionee shall have the right to exercise all Options then currently exercisable
in accordance with the terms of the applicable Option Agreement within five (5) days after the date of such notice, and/or (e) any such
other or further action as may be determined to be appropriate by the Board, in its sole discretion. Upon receipt of any consideration
referred to above by the Optionee, the Option shall immediately terminate and be of no further force and effect, including with respect
to the vested and unvested portion thereof.

 

    -7-

     

    

 

The value of the stock or other
consideration the Optionee would have received if the Option had been exercised shall be determined in good faith by the Board. In addition,
in the case of any such merger, consolidation, liquidation, sale, disposition, Sale of the Company or other circumstance, the Board may,
in its sole discretion, accelerate the vesting of any Option.

 

(e)               
Upon dissolution or liquidation of the Company, the Option shall terminate, but the Optionee (if at such time in the employment
of the Company or any Subsidiary) shall have the right, immediately prior to such dissolution or liquidation, to purchase shares of Stock
pursuant to the Option to the extent such Option is then vested.

 

(f)               
No fraction of a share of Stock shall be purchasable or deliverable upon the exercise of an Option, but in the event any adjustment
hereunder of the number of shares covered by the Option shall cause such number to include a fraction of a share, such fraction shall
be adjusted to the nearest smaller whole number of shares.

 

(g)              
Except as expressly provided herein, the issue by the Company of shares of Stock, or other securities of any class or series, or
securities convertible into or exchangeable or exercisable for shares of Stock or other securities of any class or series, for cash or
property or for labor or services either upon direct sale or upon the exercise of rights or warrants to subscribe therefor, or upon conversion
of shares or obligations of the Company convertible into such shares or other securities, shall not affect, and no adjustment by reason
thereof shall be made with respect to, the number, class or price of shares of Stock then subject to outstanding Options.

 

		17.	DEFINITIONS

 

For purposes of this Plan, the following terms shall have
the following meanings: “Aggregate Equity Investment” means the aggregate amount of all capital contributions

of the Investors in the Company
and its Subsidiaries as of the Grant Date (as defined in the applicable Option Agreement).

 

“Board”
means the board of directors of the Company or a duly authorized committee thereof. Any determination by the Board contemplated by the
Plan will be conclusive absent manifest error.

 

“Cause”
means with respect to a holder of Options (a) “Cause” as such term is defined in such holder’s employment
agreement, if any, with the Company or any Related Entity, or (b) in the absence of such agreement, “Cause” will mean
any of the following, whether occurring before or after the Plan Adoption Date: (i) the commission of a felony or other crime
involving moral turpitude or the commission of any other act or omission involving embezzlement, theft, misappropriation,
dishonesty, unethical business conduct, including bribery or similar conduct, disloyalty, fraud or breach of fiduciary duty, (ii)
reporting to work under the influence of alcohol, (iii) the use of illegal drugs (whether or not at the workplace) or other conduct,
even if not in conjunction with such holder’s duties, which could reasonably be expected to, or which does, cause the Company
or any Related Entity public disgrace or disrepute or economic harm, (iv) repeated failure to perform duties as reasonably directed
by the Board or any officer to whom such holder reports, (v) gross negligence or willful misconduct with respect to the Company or
any Related Entity or in the performance of such holder’s duties for the Company or any Related Entity, (vi) obtaining any
personal profit not thoroughly disclosed to and approved by the Board in connection with any transaction entered into by, or on
behalf of, the Company or any Related Entity, (vii) violating the expense reimbursement policies of the Company or any Related
Entity, (viii) violating any of the terms of the Company’s or any Related Entity’s established rules or policies which,
if curable, is not cured to the Board’s reasonable satisfaction within fifteen (15) days after written notice thereof to such
holder, or (ix) any other material breach of the Plan or any other agreement between such holder and the Company or any Related
Entity, which, if curable, is not cured to the Board’s reasonable satisfaction within fifteen (15) days after written notice
thereof to such holder.

 

    -8-

     

    

 

“Exchange
Act” means the Securities and Exchange Act of 1934 and the rules, regulations and interpretations thereunder, in each case as
amended from time to time, or any successor thereto.

 

“Holder”
means any holder of the Optionee Securities (including the Optionee and the Optionee’s permitted transferees).

 

“Investors”
means TOI HC I, LLC, a Delaware limited liability company, M33 Growth I L.P., a Delaware limited partnership, TOI M, LLC, a Delaware limited
liability company, OncologyCare Partners, LLC, a Delaware limited liability company, and their respective affiliates.

 

“Net
Proceeds” means, upon a Sale of the Company, the aggregate amount of (a) all cash payments actually distributed to or received
by the Investors with respect to, or as consideration in exchange for, the capital interests of the Company by the Investors at or prior
to the date of the Sale of the Company, including, without duplication, all cash dividends, distributions and sales proceeds with respect
to such capital interests, but excluding any (i) indemnification payments or proceeds from insurance policies or settlements, (ii) fees,
expenses and costs incurred in connection with the Sale of the Company, or (iii) management, transaction, consulting, advisory or board
fees earned by the Investors for services rendered; and (b) the fair market value (as determined in good faith by the Board) of any marketable
securities received by the Investors with respect to, or as consideration in exchange for, the capital interests of the Company acquired
by the Investors at or prior to the date of the Sale of the Company.

 

“Optionee”
means any person to whom an Option has been granted under the Plan pursuant to an Option Agreement.

 

“Optionee
Securities” means (a) all shares of Stock, if any, acquired by an Optionee (whether before or after the date hereof), (b)
all vested Options, if any, held by an Optionee, and (c) all securities of the Company issued or issuable with respect to the
securities referred to in clauses (a) and (b) above by way of a stock split, stock dividend, plan of recapitalization,
reorganization, or other like action. The Optionee Securities will continue to be the Optionee Securities in the hands of any Holder
other than an Optionee (excluding the Company, its Subsidiaries, the Investors and any transferees in a public offering or a Sale of
the Company).

 

    -9-

     

    

 

“Related
Entities” means the Company’s Subsidiaries, any non-natural person that receives management services from the Company
or any of the Company’s Subsidiaries, and any of such person’s Subsidiaries.

 

“Securities Act” means
the Securities Act of 1933 and the rules, regulations and interpretations thereunder, in each case as amended from time to time, or any
successor thereto.

 

“Stock” means
the Company’s common stock, par value $0.001 per share. “Stockholders Agreement” means any stockholders agreement
then in effect, as amended or modified from time to time, among the Company and the other persons named therein.

 

“Subsidiary”
means any corporation, limited liability company, partnership, association, joint stock company, trust, joint venture or unincorporated
organization of which the Company, at the time in respect of which such term is used, (a) owns directly or indirectly more than fifty
percent (50%) of the equity or beneficial interests, on a consolidated basis, or (b) owns directly or controls with power to vote, indirectly
through one or more subsidiaries, shares of capital stock or beneficial interests having the power to cast a majority of the votes entitled
to be cast for the election of directors, trustees, managers or other officials having powers analogous to those of directors of a corporation.
Unless otherwise specifically indicated, when used in this Plan, the term Subsidiary shall refer to a direct or indirect Subsidiary of
the Company or any Related Entity.

 

“Voting
Securities” means all outstanding securities of the Company entitled to vote in the election of directors of the Company.

 

		18.	AMENDMENT OR TERMINATION OF PLAN AND OPTIONS

 

The Board may,
in its sole and absolute discretion, modify, revise, suspend or terminate the Plan at any time and from time to time; provided,
however, that, if Section 16(b) of the Exchange Act is at the time applicable to the Company, then the Board may not, without the
further approval of the holders of at least a majority of the outstanding shares of the Voting Securities, (a) materially increase the
benefits accruing to Optionees under the Plan or make any “modifications” as that term is defined under Section 424(h)(3)
(or its successor) of the Code if such increase in benefits or modifications would adversely affect the availability to the Plan of the
protections of Rule 16b-3 under Section 16(b) of the Exchange Act; (b) change the aggregate number of shares of Stock which may be issued
under Options pursuant to the provisions of the Plan or the aggregate number of shares of Stock which may be issued to any single employee
under the Plan, except as provided in Section 16(b); or (c) change the class of persons eligible to receive Options. The Committee may,
in its sole and absolute discretion, amend any Option, or waive any restrictions or conditions applicable to any Option or the exercise
of the Option; provided that the Committee may not decrease the exercise price for any outstanding Option after the date of grant except
as permitted by Section 409A. Notwithstanding any other provision of this Section 18, no amendment shall adversely affect an outstanding
Option, and no termination shall terminate outstanding Options, without the consent of the holder of such Options.

 

    -10-

     

    

 

		19.	CERTAIN RIGHTS OF THE COMPANY

 

The Committee
may, in its sole and absolute discretion, also require a key employee or other person, as a condition to receiving any Option, to enter
into a noncompetition, nonsolicitation and/or confidentiality agreement or other agreement in such form as the Committee may, from time
to time in its sole and absolute discretion, determine.

 

		20.	WITHHOLDING TAXES

 

Each Optionee
shall indemnify or reimburse the Company with respect to any federal, state or local taxes of any kind that the Company or any Subsidiary
is required by law to withhold with respect to any grant, vesting, exercise or disposition of any Option, to the extent the Company or
any Subsidiary does not or cannot withhold such amount. Without limiting the generality of the foregoing, the Company and its Subsidiaries,
to the extent permitted or required by law, shall have the right to deduct from any payment(s) of any kind (including salary or bonus)
otherwise due to an Optionee, a total amount not to exceed the amount of any federal, state or local taxes of any kind required by law
to be withheld with respect to any grant, vesting, exercise or disposition of any option.

 

		21.	GOVERNING LAW; CONSTRUCTION

 

The Plan, the
Options and any Option Agreement hereunder and all related matters shall be governed by, and construed in accordance with, the laws of
the State of Delaware, without regard to conflict of law provisions.

 

Neither the
Plan nor any Option Agreement shall be construed or interpreted with any presumption against the Company by reason of the Company caused
the Plan or Option Agreement to be drafted.

 

		22.	EFFECTIVE DATE OF THE PLAN

 

The Plan shall
become effective and shall be deemed to have been adopted as on the Plan Adoption Date first above written.

 

    -11-

     

    

 

EXHIBIT A

to 2019 Non-Qualified
Stock Option Plan

 

TOI PARENT, INC.

 

 

 

Non-Qualified Stock Option Agreement

 

 

 

Subject to
the terms and conditions set forth herein and the terms and conditions of the TOI Parent, Inc. 2019 Non-Qualified Stock Option Plan (the
 “Plan”) (with capitalized terms used but not defined herein having the meanings given to them in the Plan or in the
Stockholders Agreement, as applicable), TOI Parent, Inc., a Delaware corporation (the “Company” which term shall include,
unless the context otherwise clearly requires, all Subsidiaries (as defined in the Plan) of the Company), hereby grants the following
option to purchase shares of the Company’s common stock, par value $0.001 per share (the “Stock”) to the Optionee,
and the Optionee hereby accepts such grant and agrees to be bound by the terms and conditions hereinafter set forth:

 

		1.	Name
                                            of Person to Whom the Option is Granted (the “Optionee”):                            .

 

		2.	Date of Grant of Option: [•], 2019 (the “Grant Date”).

 

		3.	An
                                            Option to acquire ______________ (       ) shares
                                            of Stock (the “Option Shares”).

 

		4.	Option
Exercise Price (per share of Stock): $________ (the “Exercise Price”).

 

	 	5.	Term of Option:	
    Subject to earlier termination under Section 9 below, this
    Option expires at 5:00 p.m. eastern time on [•], [     ]1.

 

6.                 
Grant. The Company hereby grants to the Optionee a stock option (this “Option”) to purchase from the
Company the number of shares of Stock set forth in Section 3 on the first page of this Option, upon the terms and conditions set
forth in the Plan and upon the additional terms and conditions contained herein. This Option is a non-qualified stock option and is not
intended to qualify as an “incentive stock option” pursuant to Section 422 of the Internal Revenue Code of 1986, as amended
(the “Code”).

 

7.                 
Option Price. To the extent vested, this Option may be exercised at the exercise price per share of Stock set forth in Section
4 on the first page hereof, subject to adjustment as provided herein and in the Plan.

 

 

1
10 years after Grant Date.

 

    

     

    

 

8.                 
Vesting of the Option. Subject to the terms and conditions of this Agreement, the vesting of the Optionee’s right
to exercise this Option for all of the Option Shares pursuant to this Option shall be subject to either a Time Vesting Requirement or
a Performance Vesting Requirement, each as set forth below.

 

(a)               
Time Vesting Requirement. [    ] shares2 of the Option
Shares (the “Time Vesting Options”) shall vest and be exercisable as follows: (i) twenty-five percent (25%) of the
Time Vesting Options shall vest on the first (1st) anniversary of the Grant Date and (ii) the remaining seventy-five percent
(75%) of the Time Vesting Options shall vest in equal monthly installments with the initial monthly vesting period ending at the end
of the first month after the first anniversary of the Grant Date and the last monthly vesting period ending on the fourth (4th)
anniversary of the Grant Date, in the case of each of clause (i) and clause (ii) so long as the Optionee has remained continuously employed
by the Company or one of its Subsidiaries from the date hereof through the date of such vesting anniversary. Notwithstanding the foregoing,
if Optionee has remained continuously employed by the Company or one of its Subsidiaries from the date hereof through the Sale of the
Company, any portion of the Time Vesting Options subject to the vesting requirements of this Section 8(a) which has not vested
shall immediately vest and be exercisable immediately prior to the Sale of the Company.

 

(b)              
Performance Vesting Requirement. [    ] shares3
of the Option Shares (the “Performance Vesting Options”) shall vest and be exercisable upon a Sale of the Company
only if the Optionee is, and has been, continuously employed by the Company or its Subsidiaries from the Grant Date through the date
of such Sale of the Company (the “Performance Option Employment Condition”). If the Performance Option Employment
Condition is satisfied and in connection with a Sale of the Company the Investors have received Net Proceeds on their Aggregate Equity
Investment representing a multiple of at least four times (4.0x) the Aggregate Equity Investment, one hundred percent (100%) of the Performance
Vesting Options shall vest and become exercisable upon the date of the Sale of the Company. Without limiting the foregoing, if the Performance
Option Employment Condition is satisfied and in connection with a Sale of the Company the Investors have received Net Proceeds on their
Aggregate Equity Investment representing a multiple between [two times] ([2.]0x) and [four] times ([4.]0x) their Aggregate Equity Investment,
then the following vesting schedule shall apply:

 

	Multiple on Aggregate Equity Investment	Percentage of Performance Vesting Options 

that shall vest upon a Sale of the Company
	[2.0]x	[   ]%
	[2.5]x	[   ]%
	[3.0]x	[   ]%
	[4.0]x	[   ]%

 

 

2
Note to Draft: Breakdown between time and performance vesting options will vary on a case-by-case basis.

3
Note to Draft: Breakdown between time and performance vesting options will vary on a case-by-case basis.

 

    -2-

     

    

 

For the avoidance of doubt, no
Performance Vesting Options shall vest if in connection with a Sale of the Company if the Investors have received Net Proceeds on their
Aggregate Equity Investment representing a multiple of less than [two times (2.0x)] the Aggregate Equity Investment. and all of such Performance
Vesting Options shall be automatically forfeited to the Company without any consideration whatsoever for the forfeited Performance Vesting
Options.

 

(c)               
Notwithstanding anything to the contrary contained herein, vesting of this Option shall cease immediately after a Sale of the Company,
and any portion of this Option that has not vested on or prior to the date of a Sale of the Company shall be automatically forfeited immediately
after a Sale of the Company.

 

9.             Termination of Employment. Notwithstanding anything to the contrary contained in this Option, if an Optionee is terminated
by the Company at any time prior to a Sale of the Company, no Option Shares shall continue to vest.

 

		10.	Term and Exercisability of Option.

 

(a)               
This Option shall expire on the earlier of (a) the date determined pursuant to Section 5 on the first page of this Option
and (b) immediately after a Sale of the Company, and shall be exercisable in accordance with and subject to the terms and conditions set
forth in the Plan (including but not limited to Section 12 of the Plan) and those terms and conditions, if any, set forth in Section
8 of this Option. If the Optionee dies before this Option has been exercised in full, the personal representative of the Optionee
may exercise this Option in accordance with the Plan.

 

(b)              
Notwithstanding anything contained in the Plan or this Option Agreement to the contrary, to the extent that any of the payments
and benefits provided for under the Plan, this Option Agreement or any other agreement or arrangement (including payments contingent upon
the occurrence of a Sale of the Company) between the Company or any of its Subsidiaries and the Optionee (collectively, the “Payments”)
would constitute a “parachute payment” within the meaning of Section 280G of the Code, then the Company and its Subsidiaries
shall each use commercially reasonable efforts to obtain the stockholder consent required to approve of such Payment to preclude such
Payment from being subject to the excise tax imposed pursuant to Section 4999 of the Code (the “Excise Tax”); provided,
however, that in such event the Optionee shall reasonably cooperate with the Company and shall take all actions and execute such
documents and instruments as shall be reasonably necessary to accomplish such preclusion of the Excise Tax. In the event that (i) the
stockholder consent is not obtained or (ii) the Optionee does not take the actions set forth in the proviso to the foregoing sentence,
the amount of the Payments shall be reduced to the amount that would result in no portion of the Payments being subject to the Excise
Tax.

 

    -3-

     

    

 

11.              Method
of Exercise. To the extent that the right to purchase shares of Stock has vested hereunder, this Option may be exercised from
time to time by written notice to the Company substantially in the form attached hereto as Exhibit A, stating the number of
shares of Stock with respect to which this Option is being exercised, and accompanied by (a) payment in full of the Exercise Payment
for the number of shares of Stock to be delivered, by means of payment acceptable to the Company in accordance with Section 10 of
the Plan and (b) an executed Joinder Agreement and a Spousal Consent, if applicable, pursuant to Section 17 of this Option.
Subject to the Plan and to Section 14 hereof, as soon as practicable after its receipt of such items, the Company shall
deliver to the Optionee (or other person entitled to receive the shares of Stock issuable upon exercise of this Option), at the
principal executive offices of the Company or such other place as may be mutually acceptable, a certificate or certificates for such
shares out of theretofore authorized but unissued shares or reacquired shares of Stock, as the Company may elect; provided, however,
that the time of such delivery may be postponed by the Company for such period as may be required for it with reasonable diligence
to comply with any applicable requirements of law. If the Optionee (or other person entitled to exercise this Option) fails to pay
for and accept delivery of all of the shares specified in such notice upon tender of delivery thereof, his or her right to exercise
this Option with respect to such shares not paid for may be terminated by the Company.

 

12.             
Forfeiture; Restrictions on Exercise. In addition to the restrictions set forth herein, this Option is subject to forfeiture
upon the occurrence of the events specified in Sections 12 and 16 of the Plan. The stock issued upon the exercise of this Option may be
subject to further restrictions set forth in Section 9 of the Plan and in the Stockholders Agreement.

 

13.             
Nonassignability of Option Rights. This Option shall not be assignable or transferable by the Optionee except by will or
by the laws of descent and distribution. During the life of the Optionee, this Option shall be exercisable only by the Optionee or, in
the event of the Optionee’s legal incapacity, by the Optionee’s legal representative.

 

14.             
Compliance with Securities Act. The Company shall not be obligated to sell or issue any shares of Stock or other securities
pursuant to the exercise of this Option unless the shares of Stock or other securities with respect to which this Option is being exercised
are at that time effectively registered or exempt from registration under the Securities Act of 1933, as amended, and applicable state
securities laws. In the event shares or other securities shall be issued which shall not be so registered, the Optionee hereby represents,
warrants and agrees that he or she will receive such shares or other securities for investment and not with a view to their resale or
distribution, and will execute an appropriate investment letter satisfactory to the Company and its counsel as a condition precedent to
any exercise of this Option in whole or in part.

 

15.             
Legends. The Optionee hereby acknowledges that the stock certificate or certificates evidencing shares of Stock or other
securities issued pursuant to any exercise of this Option will bear a legend setting forth the restrictions on their transferability described
in Section 13 hereof, in Section 13 of the Plan, and under any applicable agreements between the Optionee and the Company
or any of its stockholders.

 

16.             
Rights as Stockholder. The Optionee shall have no rights as a stockholder with respect to any shares of Stock or other securities
covered by this Option until the date of issuance of a certificate to him or her for such shares or other securities. No adjustment shall
be made for dividends or other rights for which the record date is prior to the date such certificate is issued.

 

    -4-

     

    

 

17.              Certain
Agreements. The Optionee hereby agrees to be bound by the terms and conditions of the Stockholders Agreement. The Optionee
hereby further acknowledges and agrees that the Option and the shares of Stock issuable upon exercise of the Option are and shall be
subject to the terms and provisions of the Stockholders Agreement; provided, however, that, in case of any conflict
between this Option Agreement and the Stockholders Agreement, this Option Agreement shall control. Upon the Optionee’s
exercise of the Option in accordance with Section 11 hereof, the Optionee agrees to execute a Joinder Agreement to the
Stockholders Agreement in the form as determined by the Committee in its sole discretion and agrees to have his or her spouse, if
applicable, execute a spousal consent by which Optionee’s spouse acknowledges and consents to the restrictions set forth in
such Stockholders Agreement (the “Spousal Consent”).

 

18.             
Equity Transfer in Connection with an Approved Sale. Consistent with the requirement set forth in the Stockholders Agreement,
the Optionee agrees that to the extent required by a buyer in connection with an Approved Sale (as defined in the Stockholders Agreement)
the Optionee shall exchange up to twenty percent (20%) of the shares of Stock purchased as a result of the exercise of this Option for
equity in the buyer (or its affiliates) in connection with such Approved Sale.

 

		19.	Confidentiality; Non-Competition; Non-Solicitation.

 

(a)            Definitions.
For purposes of this Section 19, the following terms shall have the following meanings unless the context indicates otherwise:

 

“Applicable
Area” means with respect to an Optionee, (a) “Applicable Area” as such term is defined in such Optionee’s
employment agreement, if any, with the Company or any Related Entity, or (b) in the absence of such agreement, anywhere in the States
of California, Nevada and Arizona.

 

“Business”
means the business of providing professional medical, clinical, ancillary, and related services similar to those provided by the Company
or its Subsidiaries, including oncology/cancer care, infusion, laboratory, pharmacy, physician dispensing, wellness, and clinical trials
and research services, and any related management and administrative services, as well as any other line of business actually engaged
in, or actively considered, by the Company or its Subsidiaries as of the last day Optionee holds this Option.

 

“Governmental
Body” means any federal, state, local or foreign government or quasi-governmental authority or any department, agency, subdivision,
court or other tribunal of any of the foregoing.

 

“Law”
means any federal, state, local or foreign law, statute, code, ordinance, regulation, rule, regulatory or administrative guidance, Order,
constitution, treaty, principle of common law or other restriction of any Governmental Body.

 

“Order”
means any order, award, injunction, judgment, ruling or decree entered, issued, made or rendered by any Governmental Body or arbitrator.

 

    -5-

     

    

 

(b)               Confidentiality.
The Optionee recognizes and acknowledges that Optionee has and may in the future receive certain confidential and proprietary
information and trade secrets of the Company and its Subsidiaries (the “Confidential Information”), and that such
Confidential Information constitutes valuable, special and unique property of the Company. The term Confidential Information will be
interpreted to include all information of any sort (whether merely remembered or embodied in a tangible or intangible form) that is
(i) related to the Company’s and its Subsidiaries’ current or potential business (including information received by the
Company or any of its Subsidiaries for third parties), and (ii) is not generally or publicly known. Optionee agrees not to disclose
or use for Optionee’s own account any Confidential Information without the Board’s prior written consent, except (x) to
the extent that any Confidential Information becomes generally known to and available for use by the public other than as a result
of Optionee’s acts or omissions; (y) to the extent that any Confidential Information is required to be disclosed pursuant to
any applicable law or court order; or (z) to the Optionee’s attorneys and accountants; provided, that, in the case of
subsection (z) hereof, the Optionee shall cause each Person receiving such Confidential Information to be informed that such
Confidential Information is strictly confidential and subject to this Agreement and to agree not to disclose or use such information
except as provided herein. The Optionee acknowledges and agrees that all notes, records, reports, sketches, plans, unpublished
memoranda or other documents, whether in paper or electronic form (and copies thereof), held by the Optionee concerning any
information relating to the Company’s and its Subsidiaries’ business, whether confidential or not, are the property of
the Company and will be promptly delivered to it upon the termination of the Optionee’s ownership of the Optionee
Securities.

 

(c)               
Nonsolicitation. During the Restricted Period, each Optionee shall not, directly or indirectly, in any manner (whether on
such Optionee’s own account, as an owner, operator, officer, director, partner, manager, employee, agent, contractor, consultant
or otherwise): (i) recruit, solicit or otherwise attempt to employ or retain or enter into any business relationship with any current
or former employee or independent contractor of or consultant to the Company or any Related Entity; (ii) induce or attempt to induce any
current or former employee or independent contractor of, or consultant to, the Company or any Related Entity, to leave the employ of the
Company or any such Related Entity, or in any way interfere with the relationship between the Company or any Related Entity and any of
their employees, independent contractors or consultants (in the case of (i) or (ii), a “Solicitation”); (iii) employ
or retain or enter into any business relationship with any Person who was an employee or independent contractor of or consultant to the
Company or any Related Entity; (iv) call on, solicit or service any Customer with the intent of selling or attempting to sell any service
or product similar to the services or products sold or provided by the Company or any Related Entity, or (v) in any way interfere with
the relationship between the Company or any Related Entity and any Customer, supplier, provider, licensor, licensee or other business
relation (or any prospective customer, supplier, provider, licensor, licensee or other business relationship) of the Company or any Related
Entity (including, without limitation, by making any negative or disparaging statements or communications regarding the Company, any Related
Entity or any of their operations, officers, directors or investors).

 

    -6-

     

    

 

(d)           Noncompetition.
During the Restricted Period, the Optionee shall not, directly or indirectly, in any manner, anywhere in the Applicable Area (whether
on the Optionee’s own account, or as an employee, consultant, agent, partner, manager, joint venturer, owner, operator or officer
of any other Person, or in any other capacity):

 

		i)	act in a capacity, or provide services, for any business that is the same as,
or substantially similar to, the Business;

 

		ii)	act in a capacity, or provide services, for any business that directly or indirectly
competes with the Business;

 

		iii)	act in a capacity, or provide services, for any business that directly or indirectly
competes with any other business conducted by the Company or any Related Entity during the Optionee’s employment with the Company
or any Related Entity;

 

		iv)	supervise, manage or oversee others engaging in any of the activities described
above;

 

		v)	act in a capacity or provide services in which the Optionee may disclose or use
Confidential Information;

 

		vi)	engage in the Business or manage, control, participate in, consult with, or render
services for, any other Person that engages in the Business;

 

		vii)	otherwise engage in any business, venture or activity that is competitive with
the Business; or

 

		viii)	except as permitted below, own any interest in, consult with, render services to
or otherwise assist any Person that does any of the foregoing.

 

Nothing herein
will prohibit (i) the Optionee from being a passive owner of less than five percent (5%) of the outstanding stock of any class of a corporation
which is publicly traded, so long as the Optionee has no active participation in the business of such corporation or (ii) [the Optionee
from being permitted to work as a physician as an employee of a physician practice of which he is not an owner or manager or otherwise
has the power or ability to control the management decisions of such physician practice.]4

 

(e)               
Enforcement. If, at the time of enforcement of any provision of Sections 19(c) or (d), a court shall hold
that the duration, scope or area restrictions stated therein are unreasonable under circumstances then existing, then the parties agree
that the maximum duration, scope or area reasonable under such circumstances shall be substituted for the stated duration, scope or area
and that the court shall be allowed to revise the restrictions contained therein to cover the maximum period, scope and area permitted
by law. Because the Optionee has access to proprietary information and Confidential Information, the parties hereto agree that money damages
would not be an adequate remedy for any breach of Sections 19(b), (c), or (d). Therefore, in the event of a breach
or threatened breach of Sections 19(b), (c), or (d), the Company or any of its successors or assigns may, in addition
to other rights and remedies existing in their favor, (i) attain specific performance and/or injunctive or other relief in order to enforce
or prevent any violations of the provisions hereof (without posting a bond or other security and without proving actual damages) and (ii)
if any shares of Stock have been issued to the Optionee upon the exercise of
the Option, repurchase all or any portion of such shares of Stock at the Exercise Price of such shares of Stock. In addition, in the event
of an alleged breach or violation by the Optionee of any provision of Sections 19(c) or (d), the Restricted Period shall
be tolled until such breach or violation has been duly cured. The existence of any claim or cause of action by the Optionee against the
Company or any of its affiliates, whether predicated on this Agreement or otherwise, will not constitute a defense to the enforcement
by the Company of the provisions of Sections 18(b), (c), and (d), which Sections will be enforceable notwithstanding
the existence of any breach by the Company. If the Company (x) brings any action or proceeding to enforce any provision of this Agreement
or to obtain damages as a result of a breach of this Agreement or to enjoin any breach of this Agreement and (y) prevails in such action
or proceeding, then the Optionee will, in addition to any other rights and remedies available to the Company, reimburse the Company for
any and all reasonable costs and expenses (including attorneys’ fees) incurred by the Company in connection with such action or
proceeding.

 

 

4
To apply to physician Optionees only.

 

    -7-

     

    

 

(f)               
Further Acknowledgments. The Optionee expressly agrees and acknowledges that the restrictions contained in Sections 18(c)
and (d) do not preclude the Optionee from earning a livelihood, nor do they unreasonably impose limitations on the Optionee’s
ability to earn a living. In addition, the Optionee agrees and acknowledges that the potential harm to the Company of the non-enforcement
of Sections 18(c) and (d) outweighs any harm to the Optionee of his or her enforcement by injunction or otherwise. The Optionee
acknowledges that the Optionee has carefully read this Agreement and has given careful consideration to the restraints imposed upon the
Optionee, and is in full accord as to their necessity for the reasonable and proper protection of the Confidential Information. The Optionee
expressly acknowledges and agrees that (i) each and every restriction imposed by this Agreement is reasonable with respect to subject
matter and time period and such restrictions are necessary to protect the Company’s interest in, and value of, the Company (including,
without limitation, the goodwill inherent therein), and (ii) the Company would not have consummated the transactions contemplated herein
without the restrictions contained in Sections 18(c) and (d). The Optionee understands and agrees that the restrictions
and covenants contained in Sections 18(c) and (d) are in addition to, and not in lieu of, any non-competition, non-solicitation
or other similar obligations contained in any other agreements between the Optionee and the Company.

 

20.             
Withholding Taxes. The Optionee hereby agrees, as a condition to the exercise of any portion of this Option, to provide
to the Company an amount sufficient to satisfy its obligation to withhold any federal, state and local taxes arising by reason of such
exercise (the “Withholding Amount”) by (a) authorizing the Company to withhold the Withholding Amount from his or her
cash compensation, or (b) remitting the Withholding Amount to the Company in cash; provided, however, that to the extent
that the Withholding Amount is not provided by one or a combination of such methods, the Company in its sole and absolute discretion may
refuse to issue such shares of Stock.

 

21.             
Effect Upon Employment. Nothing in this Option or the Plan shall be construed to impose any obligation upon the Company
or any Subsidiary to employ or retain in its employ, or continue its involvement with, the Optionee or interfere in any way with any right
of the Company or any of its Subsidiaries or affiliates to terminate such employment at any time for any reason whatsoever (whether for
cause or without cause) without liability to the Company or any of its Subsidiaries or affiliates.

 

    -8-

     

    

 

22.             
Time for Acceptance. This Option shall be effective as of the date an executed copy is delivered by the Company to the Optionee;
provided, however, that unless the Optionee shall return to the Company an executed copy of this Option Agreement, and,
if applicable, an executed spousal consent in the form attached hereto as Exhibit B, within fourteen (14) days after its delivery
to him or her, the Option and this Option Agreement shall be null and void.

 

23.             
Amendment. This Option Agreement, including the Plan, contains the full and complete understanding and agreement of the
parties hereto as to the subject matter hereof, and may not be modified or amended, nor may any provision hereof be waived, except by
a further written agreement duly signed by the Company and the Optionee. The waiver by either of the parties hereto of any provision hereof
in any instance shall not operate as a waiver or any other provision hereof or in any other instance.

 

24.             
Binding Effect. This Option Agreement shall inure to the benefit of and be binding upon the parties hereto and, to the extent
provided herein and in the Plan, their respective heirs, executors, administrators, representatives, successors and assigns.

 

25.             
Option Plan; Construction. The Optionee hereby acknowledges receipt of a copy of the Plan. Except as otherwise provided
in this Option Agreement, all of the terms and conditions of the Plan are incorporated herein by reference and this Option is subject
to such terms and conditions in all respects. In case of any conflict between the Plan and this Option Agreement, this Option Agreement
shall control. The titles of the sections of this Option Agreement and of the Plan are included for convenience only and shall not be
construed as modifying or affecting their provisions. The masculine gender shall include both sexes; the singular shall include the plural
and the plural the singular unless the context otherwise requires.

 

26.             
Exclusive Agreement. The Optionee hereby acknowledges and agrees that by signing this Option Agreement, the Optionee voluntarily
and irrevocably forfeits any and all rights, title, and interests the Optionee has or may have had in, to and under (a) any option agreement,
option letter, or other similar document pursuant to which the Company (or any Subsidiary or affiliate thereof) may have previously granted,
or offered to grant, options in the Company (or any Subsidiary or affiliate thereof) to the Optionee and (b) any oral or written commitment
or promise regarding options that the Company (or any Subsidiary or affiliate thereof) may have made to the Optionee, except as to any
options that have been previously exercised and paid for by the Optionee.

 

27.             
Governing Law. This Option Agreement shall be governed by and construed and enforced in accordance with the applicable laws
of the United States of America and the law (other than the law governing conflict of law questions) of the State of Delaware except to
the extent the laws of any other jurisdiction are mandatorily applicable.

 

    -9-

     

    

 

28.             
Notices. Any notice in connection with this Option Agreement shall be deemed to have been properly delivered if it is in
writing and is delivered in hand, by reputable overnight delivery service or sent by registered or certified mail, return receipt requested,
to the party addressed as follows, unless another address has been substituted by notice so given:

 

	To the Optionee:	To his or her address as listed on the books of the Company.

 

	To the Company:	
    TOI Parent, Inc.

    18000 Studebaker Road, #800

    Cerritos, CA 90703 c/o:

     

    Havencrest Healthcare Partners,
    L.P. 5221 N. O’Connor Blvd. East Tower Suite 1200

    Irving, Texas 75039 Attention: Matt D. Shofner

    Email:

     

    M33 Growth

    888 Boylston Street, Suite 500

    Boston, Massachusetts 12199-8202 Attention: Gabriel
    Ling

    Email:

     

    ROCA Partners LLC

    9460 Wilshire Blvd., Suite 850 Beverly Hills, CA 90212

    Attn: Ravi Sarin

    Email:

	 	 
	with a copy to:	
    McDermott Will & Emery LLP

    333 Avenue of the Americas, Suite 4500 Miami, Florida
    33131

    Attention: Alexander Clavero Facsimile: (305) 329-4451
    Email:

 

*   *   *   *   *

 

    -10-

     

    

 

IN
WITNESS WHEREOF, the parties hereto have executed this Option Agreement as of the date first written above.

 

 

	OPTIONEE:	 	TOI PARENT, INC.
	 	 	 
	 	 	By:	 
	[Name]	 	Name: Hilda Agajanian
	 	 	Title: President

 

    -11-

     

    

 

 

EXHIBIT A

(to Stock Option Agreement)

 

FORM FOR EXERCISE OF STOCK
OPTION

 

TOI Parent, Inc.

18000 Studebaker Road, #800

Cerritos, CA 90703 c/o:

 

Havencrest Healthcare Partners,
L.P. 5221 N. O’Connor Blvd. East Tower Suite 1200

Irving, Texas 75039 Attention: Matt D. Shofner

Email:

 

M33 Growth

888 Boylston Street, Suite 500

Boston, Massachusetts 12199-8202 Attention: Gabriel
Ling

Email:

 

ROCA Partners LLC

9460 Wilshire Blvd., Suite 850 Beverly Hills, CA 90212

Attn: Ravi Sarin

Email:

 

		RE:	Exercise of Option under TOI Parent, Inc.
	 	 	2019
Non-Qualified Stock Option Plan (the “Plan”) 

 

Ladies and Gentlemen:

 

Please
take notice that the undersigned hereby elects to exercise the stock option granted on                
by and to the extent of purchasing                       
shares of common stock, par value $0.001 per share (the “Stock”), of TOI Parent, Inc. (the “Company”)
for the exercise price of $                  
per share, subject to the terms and conditions of the Stock Option Agreement between                      
and the Company dated as of                    
(the “Option Agreement”). Capitalized terms used but not defined herein shall have the meanings given to such
terms in the Plan.

 

The undersigned
encloses herewith payment, in cash or in such other property as is permitted under the Plan, of the Exercise Payment for said shares and
has made a provision with the Company for the Withholding Amount.

 

     

     

    

 

In connection with the exercise of
the Option, the undersigned represents to the Company as follows:

 

(a)               
The undersigned is acquiring the Stock solely for investment purposes, with no present intention of distributing or reselling any
of the shares of Stock or any interest therein. The undersigned acknowledges that the Stock has not been registered under the Securities
Act of 1933, as amended (the “Securities Act”).

 

(b)              
The undersigned is aware of the Company’s business affairs and financial condition and has acquired sufficient information
about the Company to reach an informed and knowledgeable decision to acquire the Stock.

 

(c)               
The undersigned understands that the Stock is a “restricted security” under applicable U.S. federal and state securities
laws and that, pursuant to these laws, the undersigned must hold the Stock indefinitely unless it is registered with the Securities and
Exchange Commission and qualified by state authorities, or unless an exemption from such registration and qualification requirements is
available. The undersigned acknowledges that the Company has no obligation to register or qualify the Stock for resale. The undersigned
further acknowledges that if an exemption from registration or qualification is available, it may be conditioned on various requirements
including, but not limited to, the time and manner or sale, the holding period for the Stock, and requirements relating to the Company
which are outside of the undersigned’s control, and which the Company is under no obligation to and may not be able to satisfy.

 

(d)              
The undersigned understands that there is no public market for the Stock, that no market may ever develop for the Stock, and that
the Stock has not been approved or disapproved by the Securities and Exchange Commission or any other federal, state or other governmental
agency.

 

(e)               
The undersigned understands that the Stock is subject to certain restrictions on transfer set forth in the Plan. Both the Plan
and the Option Agreement are incorporated herein by reference.

 

(f)               
The undersigned understands that any Stock purchased hereunder shall be subject to the Stockholders Agreement of the Company as
it may be amended from time to time (“Stockholders Agreement”), a copy of which has been provided to the undersigned,
and that it is a condition to the exercise of my Option that the undersigned executes a signature page of the Stockholders Agreement,
agreeing to be bound thereby and that the undersigned’s spouse, if applicable, must sign the Spousal Consent. The undersigned and
his or her spouse has had a full and fair opportunity to review the Stockholders Agreement prior to exercising the Option.

 

	 	Very truly yours,
	Date	 
	 	 
	 	(Signed by                    or
  other party duly exercising option)

 

     

     

    

 

Note:
If Options are being exercised on behalf of a deceased Optionee, then this Notice must be signed by such Optionee’s personal representative
and must be accompanied by a certificate issued by an appropriate authority evidencing that the individual signing this Notice has been
duly appointed and is currently serving as the Optionee’s personal representative under applicable local law governing decedents’
estates.

 

     

     

    

 

EXHIBIT B

(to Stock Option Agreement)

 

FORM OF SPOUSAL CONSENT

 

I acknowledge
that I have read the foregoing Stock Option Agreement and that I know its contents. I acknowledge and agree that capitalized terms used
and not defined in this spousal consent shall have the meanings ascribed to such terms in the Stock Option Agreement. I am aware that
by the provisions of the Stock Option Agreement, my spouse agrees, among other things, to the granting of rights to purchase and to the
imposition of certain restrictions on the transfer of the Optionee Securities, including my community interest therein (if any), which
rights and restrictions may survive my spouse’s death. I hereby consent to such rights and restrictions, approve of the provisions
of the Stock Option Agreement, and agree that I will bequeath any interest which I may have in said Optionee Securities or any of them,
including my community interest, if any, or permit any such interest to be purchased, in a manner consistent with the provisions of the
Stock Option Agreement. I direct that any residuary clause in my will not be deemed to apply to my community interest (if any) in such
Optionee Securities except to the extent consistent with the provisions of the Stock Option Agreement.

 

I further agree
that in the event of a dissolution of the marriage between myself and my spouse, in connection with which I secure or am awarded any Optionee
Securities or any interest therein through property settlement agreement or otherwise, (a) I will receive and hold said Optionee Securities
subject to all the provisions and restrictions contained in the Stock Option Agreement, including any option of the Company, the Investors
or other stockholder or optionholder to purchase such shares or interest from me, and (b) I hereby irrevocably constitute and appoint
my spouse, as true and lawful attorney and proxy (the “Proxy”) of my Optionee Securities with full power of substitution,
to vote (at any annual or special meeting or by written consent) such Optionee Securities which I would be entitled to vote as a stockholder,
together with any and all Optionee Securities issued in replacement or in respect of such Optionee Securities by dividend, distribution,
stock split, reorganization, recapitalization or otherwise.

 

I also acknowledge
that I have been advised to obtain independent counsel to represent my interests with respect to this spousal consent.

 

	Date:	 	 	 	 
		Name of Spouse:	 
	 	 	 
	 	Name of Optionee:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00337-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00337-of-00352.parquet"}]]